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In the past twenty years, far-reaching studies of molecular and cellular processes have reached
a milestone in their maturation, and the knowledge from these studies was ready to apply
at higher organizational levels. At that time, rodent models were long established. However,
methods were inappropriate to image a whole rodent organ, such as the mouse brain, which
drove the emergence of a new range of imaging techniques, later gathered under the name
mesoscopy. Mesoscopic techniques filled a gap between classical microscopy and medical
imaging techniques, such as magnetic resonance imaging, and X-ray computed tomography.
They allow the acquisition of centimeter-sized samples. In this thesis, we focus on one of
these mesoscopic imaging techniques called optical projection tomography, or OPT, and its
potential application to Alzheimer’s disease (AD) research. We review the fundamentals of
OPT and describe the filtered back-projection algorithm, which is the primary tomographic
reconstruction method of this technique. We also go through the implementation of OPT for
whole mouse brain imaging, including sample preparation. We show that OPT is suitable to
image the whole brain anatomy based on endogenous fluorescence, and the whole neural
vasculature as well as amyloid plaques (a hallmark of AD) with adequate fluorescent markers.
Then, we dwell on the characterization of OPT instruments. We give some insights on the
instrument point spread function and discuss the influence of the number of projections on
the quality of the reconstructed image. Afterward, we illustrate the application of OPT to study
amyloidosis progression in a preliminary cross-sectional study, where we have used supervised
learning to quantify the amyloid plaque load. In this study, we show that OPT can be used
to quantify amyloidosis in whole mouse brains and that comparison between individuals of
different age can be performed. Imaging of a whole mouse brain is unquestionably necessary.
At this scale though, it has some constraints. We present the limitations of OPT, and we share
how we think they can be circumvented by combining this modality with another microscopy
technique, namely structured illumination microscopy. We see that this other microscopy
technique has the potential to produce high-resolution zooms in selected regions of interest
based on a prior OPT acquisition. The results presented in this work have led to the duplication
of our OPT instrument in Lund University, and we hope they will help to foster advances in
OPT and broaden its range of application. We also hope that this work will contribute to
making OPT more accessible and user-friendly.
Key words: optical projection tomography (OPT); Alzheimer’s disease (AD); whole mouse




Au cours des vingts dernières années, des études de grande portée sur les processus molé-
culaires et cellulaires arrivées à maturité et la connaissance de ces études était prête à être
appliquée à des niveaux organisationnels plus élevés. À cette époque, les modèles de rongeurs
étaient établis depuis longtemps. Cependant, les méthodes existantes étaient inappropriées
pour imager des organes de rongeurs entiers, tel que le cerveau de souris. Cela conduisit à
l’émergence d’une nouvelle gamme de techniques d’imagerie, plus tard rassemblées sous le
nom de mesoscopie. Ces techniques mesoscopiques comblèrent le vide entre la microscopie
classique et les techniques d’imagerie médicales, telles que l’imagerie par résonance magné-
tique et la tomodensitométrie aux rayons X, en permettant l’acquisition d’échantillons de
taille centimétrique. Dans cette thèse, nous nous intéressons à une techniques d’imagerie
mesoscopique appelée tomographie par projection optique, ou TPO, et à son application
à la recherche sur la maladie d’Alzheimer. Nous revisitons les fondamentaux de la TPO et
nous décrivons l’algorithme de rétro-projection filtrée, qui est le moyen de reconstruction
tomographique au cœur de cette technique. Nous allons passons également en revue une
implémentation de la TPO pour l’imagerie de cerveaux de souris entiers incluant la prépara-
tion des échantillons. Nous montrons que la TPO est adéquate pour l’imagerie de l’anatomie
des cerveaux entiers basée sur la fluorescence endogène et la vascularisation cérébrale, ainsi
que les plaques d’amyloïde (une signature caractéristique de la maladie d’Alzheimer) avec
des marqueurs fluorescents adéquats. Nous nous penchons ensuite sur la caractérisation
des instruments de TPO. Nous donnons un aperçu de la fonction d’étalement du point de
l’instrument et nous discutons l’influence du nombre de projections dans la qualité de l’image
obtenue après reconstruction. Après quoi, nous illustrons l’application de la TPO à l’étude de
la progression de l’amyloïdose dans une étude transversale préliminaire où nous avons utilisé
l’apprentissage supervisé pour identifier et quantifier la charge de plaque d’amyloïde. Dans
cette étude, nous montrons que la TPO peut être utilisée pour quantifier l’amyloïdose dans les
cerveaux de souris entiers et qu’une comparaison entre individus d’âges différents peut être
réalisée. L’imagerie de cerveaux de souris entiers est sans conteste nécessaire. À cette échelle
cependant, elle impose certaines contraintes. Nous présentons les limitations de la TPO et
nous partageons comment nous pensons qu’elles peuvent êtres dépassées en combinant cette
modalité avec une autre technique de microscopie, la microscopie à illumination structurée.
Nous verrons que la microscopie à illumination structurée a le potentiel de produire des
zooms à haute résolution dans des régions d’intérêts basée sur une acquisition TPO antérieure.
Les résultats présentés dans cette thèse ont conduit à la duplication de notre instrument de
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TPO à l’univérsité de Lund et nous espérons qu’ils pourront aider à favoriser les avancées en
TPO et élargir son champ d’applications. Nous espérons aussi que ce travail contribuera à
rendre la TPO plus accessible et facile à utiliser.
Mots-clés : tomographie par projection optique (TPO); maladie d’Alzheimer; imagerie du
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3D imaging is an essential field of biomedical research [1] with numerous applications in
medicine and life sciences. From drug evaluation studies [2] to cellular and molecular diag-
nostics [3], tridimensional imaging of biomedical specimen is performed at different scales, as
































Figure 1.1 – Representation of the trade-off between resolution and specimen size in common
3D biomedical imaging techniques. Until twenty years ago, there was a gap between micro-
scopic and macroscopic imaging techniques. Mesoscopic imaging techniques have started to
fill it since then due to a growing interest in small animal imaging. aKhalil et al. [4], bStucht et
al. [5], c du Plessis et al. [6], d Baltes et al. [7], e Ntziachristos et al. [8], f Sharpe et al. [9], g Pende
et al. [10], hFercher et al. [11], i Ntziachristos [12], j Rehemtulla et al. [13], k Deffieux et al. [14].
On one hand, macroscopic imaging techniques, such as X-ray computed tomography (CT) [15,
16], positron emission tomography (PET) [17], single-photon emission computed tomography
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(SPECT) [4] and magnetic resonance imaging (MRI) [18], are used to diagnose human patients.
They can produce 3D images of the whole human body with different levels of specificity and
a resolution from 0.2 to 8 mm.
On the other hand, optical microscopic imaging techniques, such as confocal microscopy [19],
multiphoton microscopy [20], and optical coherence microscopy [11], are used for cell and
tissue imaging [21]. In optical microscopy, the specimen size generally falls between 100 µm
and 1 mm with a resolution from 5 µm, down to a few hundreds of nanometers [22] (for
super-resolution microscopy).
Over the past decades, a growing interest for small animal imaging [23] has fostered the emer-
gence of 3D imaging techniques operating at an intermediate regime called mesoscopy [12].
In this regime, the specimen size range from few millimeters to several centimeters with a
resolution of 200 µm to 3 µm, filling the gap between microscopy and the macroscopic imaging
techniques.
Mesoscopy
A variety of imaging techniques are today available in the mesoscopic imaging range. A
subset of these techniques is adapted from their macroscopic counterpart. Micro-CT [24], for
example, is the equivalent of CT for small animal imaging. Driven by recent technological
progress, micro-CT is widely used in small animal cancer research [25]. It offers a resolution of
approximately 50 µm in whole rodents and a sensitivity to tumors in vivo. Micro-MRI [26] is the
equivalent of MRI for small animal imaging. The resolution increase is obtained by different
means, such as increasing the magnetic field strength [27] and using cryogenic detection
devices [7]. Micro-MRI has been used for in vivo visualization of amyloid plaques [28] (a
hallmark of Alzheimer’s disease, see below), it has a resolution of 30 to 80 µm and excellent
sensitivity to soft tissues. Micro-CT and MRI have both similar resolutions, they mainly differ
in their contrast mechanism which leads to differences in specificity, and can be performed
in vivo. However, they require expensive instruments that have a high maintenance cost,
restricting their availability. Fortunately, these two imaging techniques are only a small sample
of the available mesoscopic technologies.
Functional ultrasound imaging (fUS) [14] measures echoes from sound waves transmitted
through the organ to retrieve 3D images in vivo. It is sensitive to blood flow, allowing to
perform functional imaging of the brain at a high temporal resolution and with a spatial
resolution down to 100 µm.
Optoacoustic tomography (OA) [29, 30] detects ultrasounds upon absorption of an excitation
light beam, increasing the detected signal resolution in deep tissues. In the mesoscopic regime,
OA has a resolution of approximately 100 µm [8] and has been used to image the vasculature
in whole mouse brains in vivo [31]. This technique requires direct contact with the specimen
to guarantee a good transmission of the sound waves.
2
Bioluminescence imaging (BLI) [32] is an optical imaging technique based on the detection
of chemically-induced fluorescence. BLI has been used in small animal cancer research [13]
and can be used in vivo. Bioluminescence imaging in mammals requires the introduction
of a transgene leading to the expression of enzymes such as Firefly or Renilla luciferase,
which upon interaction with their substrates generate light. The method is characterized by a
high sensitivity as the intrinsic bioluminescence background signal is absent in mammalian
cells. Due to a pronounced scattering of the emitted photons in biological tissues, the spatial
resolution of BLI is approximately 1 mm.
Ultramicroscopy [33] and light-sheet microscopy [34] are probably the most commonly used
among the mesoscopic fluorescence imaging techniques. Both techniques use a sheet of light
to illuminate a single section of the sample selectively. The subtle difference between these
two is that, in state-of-the-art light sheet microscopy, the trend is in increasing the resolution
and going towards super-resolution microscopy [35], while in ultramicroscopy, the aim is to
enhance the light-sheet performance at the mesoscopic-scale and to provide small animal
imaging capacity [36, 37, 38, 39]. Ultramicroscopy has been used in developmental studies of
whole zebra fish in vivo [40], and fruit flies [41, 10]. Ultramicroscopy also found applications
in imaging of the whole mouse brain neuroanatomy [42] and amyloidosis in an Alzheimer’s
disease model [43]. This technique can achieve a resolution down to the cellular level in whole
model organisms using engineered sheets of light [10].
Finally, optical projection tomography (OPT) [9] finds a sweet spot among this range of
mesoscopic imaging techniques.
Optical projection tomography
OPT is sometimes described as an optical equivalent of CT [44]. It can have a resolution down
to 5 µm in centimeter-sized samples [45], and it can use fluorescent and colored dyes [9].
OPT has been applied to the zebra fish vasculature in vivo [46], whole mouse pancreas in the
study of diabetes [47, 48, 49], and whole mouse brain neuroanatomy [50]. Additionally, helical
scanning enables imaging of elongated samples, such as the mouse spinal cord [51]. Another
interesting feature is that open hardware allows transforming any microscope into an OPT
instrument [52] or building one from the ground up [45]. Moreover, improved reconstruction
methods can provide an increase in the resolution [53, 54].
In this thesis, we developed a custom OPT instrument for whole mouse organ imaging [55].
We characterized the instrument using fluorescent microparticles, and we investigated the
influence of the number of projections on the final image. Finally, we evaluated the use of




AD is a neurodegenerative disorder and the most prevalent cause of dementia [56]. Dementia
is a syndrome altering functional, cognitive, and behavioral ability, hampering independent liv-
ing capacity, and ultimately leading to death [57]. In 2001, a panel of 12 experts estimated 24.3
million people with dementia worldwide and projected 4.6 million new cases each year [58].
The same experts also predicted that the increase in new cases will double every 20 year and
that by 2040 dementia will affect 81.1 million people. Another study reported a projection of
106.2 million people with AD in 2050, confirming the alarming numbers [59] and making AD a
public health priority [60].
In 2011, a review of the diagnostic guidelines for AD, established in 1984 [61], suggested that
the clinical diagnosis of AD, based on multiple information such as medical history, cognitive
and personality tests, etc., had a sensitivity of 81 % and a specificity of 70 % based on 27 years
of experience [62]. Additionally, there can be a long period between the earliest pathogenic
events in the brain of an AD patient and the first evidence of cognitive decline; this is referred
to as the preclinical states of AD [63]. The preclinical states of AD are asymptomatic and, in
some cases, will remain so until the patient’s death. In this case, only a diagnosis post mortem
can unveil the characteristic brain lesions.
Two hallmark proteins have been identified in the brain of AD patients: the amyloid-β and
tau protein [64]. In this thesis, we focus on the amyloid-β and the amyloid cascade hypothe-
sis [65, 66]. Amyloid-β is the principal component of amyloid plaques, which deposit in the
extracellular space in the form of small aggregates from 10 to 100 µm in size. In the amyloid
cascade hypothesis, it is believed that amyloid plaques are the crucial event of AD pathology.
In this regard, the visualization of amyloid plaques plays a pivotal role in AD research, as
illustrated in Figure 1.2.
The recent development of the Pittsburgh Compound-B (PIB) in 2004 [67] revolutionized in
vivo imaging of amyloid pathology in humans with PET (Figure 1.2(a)). There have been efforts
to incorporate PET of amyloid-β in the clinical diagnosis of AD, and its importance regarding
asymptomatic preclinical states has been highlighted [69] as previous guidelines failed to
establish a diagnostic before the patient’s death. The binding of PIB to amyloid-β assemblies
is well characterized [70], and the tracer design gives the specific spatial representation of
the amyloid burden in PET images. However, the resolution of PET is insufficient to study
individual amyloid plaques, which is rather performed on transgenic mouse models [71].
In histopathology, the brain is mechanically sliced and marked with probes of amyloid
plaques [72]. The tissue sections are then imaged with a widefield microscope (Figure 1.2(b)
and (c)). The resolution of modern microscopes allows visualizing individual amyloid plaques,
but histopathology is rarely applied in 3D and suffers from cutting artefacts due to mechanical
slicing. Additionally, histopathology is performed ex vivo.

















Figure 1.2 – Amyloid plaque imaging. (a) in vivo PET images of human subjects with Pittsburgh
Compound-B (edited from Figure 4 in the work of Klunk et al. [67]). Left: 67-year-old healthy
control subject; right: 79-year-old AD patient. (b) Histological section from a mouse brain of
an AD model marked for amyloid plaques. (c) Corresponding zoom in the histological section.
(d) Ultramicroscopy images of AD mouse brains at different age and marked for amyloid
plaques (edited from Figure 3 in the work of Jährling et al. [43]). Scale bar: 1 mm. (e) OCM
image of amyloid plaques in an AD mouse brain with intrinsic contrast (edited from Figure 3
in the work of Bolmont et al. [68]). (f) Micro-MRI images of plaques with intrinsic contrast in
AD mouse brains (edited from Figure 3 in the work of Jack et al. [28]).
probe (Figure 1.2(d)) with cellular resolution [43]. OCM can perform 3D intrinsic imaging of
the plaques in regions of interest of an AD mouse brain in vivo [68] (Figure 1.2(e)) but is hardly
applicable to a whole mouse brain. Micro-MRI also shows an in vivo intrinsic contrast of the
amyloid plaques in whole AD mouse brains [28] in 3D. However, to the best of our knowledge,
there has not been an attempt to image amyloid plaques in the whole brain of an AD mouse
with OPT.
Main contributions
The main scientific contributions of this thesis consist of three first author papers, each
composing a chapter (Chapter 3-5).
In the first research article by D. Nguyen, P. J. Marchand, A. L. Planchette, J. Nilsson, M. Sison, J.
Extermann, A. Lopez, et al. called “Optical projection tomography for rapid whole mouse brain
imaging” published in Biomedical Optics Express [55], a custom OPT instrument designed
for whole mouse organ imaging is described. The OPT instrument can image samples as
large as 8 cm3 with a resolution of approximately 30 µm in a matter of minutes. Additionally,
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sample preparation is described and includes an optimized clearing protocol, the duration
of which is reduced to a couple of days instead of weeks. Finally, images of the mouse brain
neuroanatomy, vasculature, and amyloid plaque demonstrate the instrument performance.
In the second research article by D. Nguyen, O. Martin, A. C. Descloux, D. Van De Ville, T.
Lasser, and A. Radenovic called “Practical aspects of optical projection tomography imaging
exemplified with whole mouse organs” submitted to Optics Express (December 2018), several
practical considerations related to the use of OPT are investigated. A new agarose embedding
protocol, which standardizes sample preparation and reduces the risk of image artefacts,
is detailed. Images of fluorescent microparticles are shown in view of understanding the
instrument specifications, and the effect of the number of projections on the reconstructed
image quality is studied.
In the last research article by D. Nguyen, V. Uhlmann, A. L. Planchette, P. J. Marchand, D. Van De
Ville, T. Lasser, and A. Radenovic called “Supervised learning to quantify amyloidosis in whole
brains of an Alzheimer’s disease mouse model acquired with optical projection tomography”
submitted to Biomedical Optics Express (December 2018), OPT images of amyloid plaques in
whole mouse brain are quantified relying on a supervised learning algorithm to evaluate the
disease progression in a preliminary cross-sectional study.
Thesis organization
In Chapter 2, the general theory of tomographic reconstruction is introduced, and the filtered
back-projection algorithm is derived. Then, the use of optical projections in tomographic
reconstruction and underlying artefacts that might arise are discussed. In Chapter 3, the imple-
mentation of a custom OPT instrument designed for whole mouse organ imaging is described
in the form of a first research article. This work also showcases whole mouse brain imaging of
the neuroanatomy, vasculature, and amyloid plaques, together with the corresponding sample
preparation protocols. Practical aspects of OPT acquisition are examined in Chapter 4. This
second research article includes a new agarose embedding protocol, images of fluorescent
microparticles, and an evaluation of the influence of the number of projections on the recon-
structed image quality. In Chapter 5, OPT is combined with supervised learning to quantify
the progression of amyloidosis in mouse brains of an Alzheimer’s disease model in a third
research article. Preliminary results to bridge imaging scales by merging OPT with structured
illumination microscopy are presented in Chapter 6. The remaining challenges are discussed
with a focus on optical aberrations arising in whole mouse organ imaging, and the thesis
concludes with a personal paragraph summarizing my work at the Laboratoire d’Optique
Biomédicale. Finally, a collection of unpublished images are showcased in a portfolio gallery
in Appendix A.
6
2 OPT theory, algorithm, and practical
aspects
Fully grasping the 3D representation of an object is an ambitious exercise. Instead, we prefer
to understand the spatial nature of things by looking at their cross-sections. Think of the floor
plan of a building or a technical drawing in a user manual. We call “tomography” the range of
techniques that can produce 3D images of objects in cross-sections. From that definition, it
follows that optical projection tomography (OPT) is the reconstruction of 3D images in cross-
sections based on optical projections of a sample. A projection is the flattened representation
of an object via a physical phenomenon. For example, the shadow we cast on the floor is a
projection resulting from sunlight absorption and reflection by our body. Projections differ
from cross-sections in the sense that they are not a strict representation of the object in a
plane of observation. Instead, they describe the response to a physical phenomenon from a
certain point of view. In the shadow example, it is deformed by the sun’s position and changes
throughout the day. For optical projections, the physical phenomena are essentially light
absorption and fluorescence emission.
In this Chapter, I introduce a general scheme for tomographic reconstruction (Section 2.1)
adapted from the book of Kak and Slaney [73]. This scheme has notably been applied to
X-ray computed tomography (CT), and I will discuss it first in that context. I will start with a
mathematical definition of the projection process, also known as the Radon transform (Sec-
tion 2.1.1). I will pursue with the central slice theorem (Section 2.1.2), another essential result
to understand tomographic reconstructions. Then, I will present the classical tomographic
reconstruction scheme (Section 2.1.3), called filtered back-projection (FBP). I will also discuss
the peculiarities of optical projections, how to implement tomographic reconstruction in OPT
(Section 2.2), and the possible image artefacts that might arise (Section 2.2.1). Finally, I will
give some details about the practical aspects of OPT and in particular the optional optical
clearing necessary for opaque samples (Section 2.3). These aspects will be further discussed
in a dedicated chapter (Chapter 4).
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2.1 Tomographic reconstruction
Our journey to understanding tomographic reconstruction begins with the concept of radio-
graphs. A radiograph is a photographic film that was exposed to X-rays passing through a
specimen. Being initially transparent, the film darkens upon an increasing X-rays exposure.
Hard tissues, such as bones, absorb a substantial amount of radiation, leaving transparent
zones on the film. Soft tissues such as organs, in contrast, have lower radiation absorption,
resulting in translucent shades on the film. Radiographers then place the exposed film over a
homogenous light-emitting surface to appreciate the different contrasts in view of a patient’s
diagnosis. A radiograph is, therefore, a projection based on X-ray absorption in a specimen.





where A is the absorbance, I0 is the initial radiation intensity, I is the radiation intensity after
a distance l traveled inside the specimen, and µ is a specimen-and-radiation-dependant ab-
sorption coefficient. In Section 2.1.1, we derive a mathematical formulation for the generation
of projections which captures the problem of radiography.
2.1.1 Radon transform




f (x, y)δ(x cosθ+ y sinθ− t )dxdy, (2.2)
with δ the Dirac impulse, transforms a 2D function f , with spatial coordinates (x, y), into
a line integral Pθ, with remaining spatial coordinate t , along a straight direction given by
arbitrary angle θ. This transform was first introduced by the Austrian mathematician J. Radon
in 1917 [75] and sets a formalism for the generation of projections. An illustration of the Radon
transform applied to a mouse brain section is shown in Figure 2.1. In this example, parallel
X-rays, represented by gray arrows, traverse the sample f (x, y) at an arbitrary angle θ. Each
ray accumulates the values of f in its direction of propagation and determines the value Pθ(t )
of the line integral at the corresponding position t . This line integral is a 1D radiograph of
the mouse brain section, and Pθ describes the absorbance of X-rays under an angle θ. In 3D,
the radiograph of a specimen is a 2D image composed of the 1D radiographs of each of its
sections.
Figure 2.1 also depicts the fundamental limitation of radiographs, which is that the projection
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Figure 2.1 – Illustration of the Radon transform. A 2D section of a mouse brain f is projected
to a line integral Pθ at arbitrary angle θ.
is made at the expense of a reduction in data dimensionality materialized by a loss of depth
information. In other words, it is impossible to know which depth of the brain section con-
tributed most to a given value Pθ(t ) in the line integral. Similarly, it is unrealistic to deduce the
morphology of a person based solely on the shadow cast on the floor at one point in time. The
inclusion of a time notion was intentional here because if that person starts to move and turns
herself or himself around, we can get a better feeling for morphology by looking at the shadow
over time. This is the underlying concept of CT.
In CT, a collection of projections are acquired at different angles over 180◦ to recover the
otherwise lost depth information. The intuition that the 3D nature of an object can be retrieved





Pθ(x cosθ+ y sinθ)dθ, (2.3)
where fbp is the reconstructed specimen section, also called the “back-projection”. By applying
this inversion to each section, a 3D image of the specimen can be reconstructed. The back-
projection of a single specimen section is illustrated in Figure 2.2. The acquisition of three




, and P 7
9pi
in Figure 2.2(a).
These projections are then back-projected in the reconstruction space in Figure 2.2(b). In this
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process, each projection is replicated throughout the reconstruction space in its direction of
acquisition. This is carried out because the depth information has been lost and it is impossible
to determine from which depth each contribution to the line integral originated from. Finally,
in Figure 2.2(c), a back-projection from 600 projections separated by 0.3◦ is shown. The result
is a blurred reconstruction of the original specimen section. While the overall morphology can
be deduced, from that image, fine details disappear. The principal method to circumvent this
issue is to incorporate an additional filtering step in the back-projection operation. Before
diving into the details of the filtered back-projection, another essential mathematical result
is needed. This result is known as the central slice theorem (Section 2.1.2), also sometimes
called the projection slice theorem or the Fourier slice theorem.
(a) (b) (c)





, and P 7
9pi




9pi in radians. (b) Direct inversion of
the Radon transform from the three projections. Each projection is copied along the direction
of acquisition throughout the whole depth of the reconstruction space. This process is referred
to as back-projection. (c) Back-projection of the mouse brain section based on 600 projections
separated by 0.3◦, the result is a blurred image of the mouse brain section.
2.1.2 Central slice theorem





where fˆpol is the 2D Fourier transform of a section in polar coordinates (ω,θ), and Pˆθ is the 1D
Fourier transform of the line integral from the Radon transform at corresponding angle θ. The
proof of this theorem is given here for θ = 0.




f (x, y)e−jω(x cosθ+y sinθ)dxdy. (2.5)




f (x, y)e−jωx dxdy. (2.6)
Since there is only an x-dependency in the exponential factor, the integration order in (2.6)















where the x- and t−coordinates of the Radon transform (2.2) are confounded. Finally, what
remains on the right-hand side of (2.8) is the definition of the 1D Fourier transform of the line
integral that is
fˆpol(ω,0)= Pˆ0(ω). (2.9)
This proof holds without loss of generality to other values of θ thanks to the rotation properties
of the Fourier transform.
11
Chapter 2. OPT theory, algorithm, and practical aspects
The central slice theorem tells us that an infinite number of Fourier-transformed line integrals
are equivalent to the 2D Fourier transform of an object section f . Since the inversion of the
Fourier transform is a well-known result of mathematics, the central slice theorem gives us
a different way of reconstructing the object section. Indeed, we can acquire line integrals
from an object, apply a Fourier transform to each of them, compose a 2D spectrum, and then
use an inverse Fourier transform in 2D. This algorithm is also referred to as direct Fourier
reconstruction. In practice, the number of line integrals we can acquire is finite, and the
Fourier space is interpolated, which is a delicate operation prone to artefacts during the
reconstruction [76]. However, the central slice theorem provides a framework to filter line
integrals in the Fourier domain, which leads us to the filtered back-projection algorithm.
2.1.3 Filtered back-projection
The filtered back-projection algorithm is the most used approach for tomographic reconstruc-
tion. It can be derived from the definition of the 2D inverse Fourier transform




fˆ (ωx ,ωy )e
j(ωx x+ωy y)dωx dωy , (2.10)
where fˆ is the 2D Fourier transform of f in Cartesian spatial frequencies (ωx ,ωy ). This 2D
Fourier transform can be rewritten in polar coordinates in (2.10), which leads to







jω(x cosθ+y sinθ)dωdθ, (2.11)
where ω=
√
ω2x +ω2y , θ = arctan ωyωx , and ωdωdθ = dωx dωy . Using the central slice theorem
(2.4), (2.11) becomes







jω(x cosθ+y sinθ)dωdθ. (2.12)
The next step in the derivation of the FBP algorithm is to split the integration over θ in (2.12)



















jω(x cosθ+y sinθ)dωdθ. (2.14)



















ωPˆθ−pi(ω)e−jω(x cosθ+y sinθ)dωdθ. (2.16)
Besides, it can be shown that
Pˆθ−pi(ω)= Pˆθ(−ω). (2.17)
Proof. Using (2.4) we can rewrite the left-hand side of (2.17) as
Pˆθ−pi(ω)= fˆpol(ω,θ−pi). (2.18)
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Using again (2.4), we can rewrite the right-hand side of (2.19) as
fˆpol(−ω,θ)= Pˆθ(−ω). (2.20)
Therefore, by combining (2.18), (2.19), and (2.20) we get
Pˆθ−pi(ω)= Pˆθ(−ω). (2.21)







ωPˆθ(−ω)e−jω(x cosθ+y sinθ)dωdθ. (2.22)







(−ω)Pˆθ(ω)ejω(x cosθ+y sinθ)dωdθ. (2.23)
We can now rewrite (2.12) as the sum of (2.13) and (2.23) as






|ω|Pˆθ(ω)ejω(x cosθ+y sinθ)dωdθ, (2.24)
which is the FBP. It is equivalent to a back-projection (2.3), where each line integral is Fourier-
transformed, multiplied by a term |ω|, and transformed back to the spatial domain, exactly as
in a filtering operation. The filter transfer function H , defined as
H(ω)= |ω|, (2.25)
describes a ramp emphasizing high spatial frequencies in the line integrals and compensating
for the blurring occurring in the back-projection process. This filter is also known as the
14
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Ram-Lak filter (see Figure 2.3).





















Figure 2.3 – Plot of the FBP filters transfer function. The Ram-Lak filter is used to reconstruct
an image from noiseless projections. It linearly emphasizes the high spatial frequencies in the
line integrals to retrieve a sharp reconstruction after back-projection. In practice, projections
are usually corrupted by high-spatial-frequency noise, which would be amplified by the Ram-
Lak filter. To mitigate this effect, the Shepp-Logan filter can be used. It is the Ram-Lak filter
windowed by a cardinal sine function, which attenuates the gain in the very high spatial
frequencies.
The FBP algorithm is illustrated in Figure 2.4. A specimen section, such as a mouse brain
(Figure 2.4(a)) is Radon-transformed at multiple angles over 180◦. The resulting line integrals
form the columns of a matrix called a sinogram (Figure 2.4(b)). A ramp filters the sinogram in
the Fourier domain (Figure 2.4(c)), and is then back-projected to retrieve a sharp reconstruc-
tion of the specimen section (Figure 2.4(d)). Practically, the FBP algorithm is implemented
with a finite number of line integrals, and spatial-domain-interpolation is required to fill the
reconstruction space consistently. Throughout this work, we use linear interpolation for this
purpose. Moreover, the Ram-Lak filter is an ideal filter, which does not account for noise in the
projections. Indeed, the high-frequency-noise recorded during the acquisition of projections
is intensified by the ramp |ω|. Therefore, FBP filters are usually combined with a window
function that attenuates the gain in the highest spatial frequencies. In the remainder of this
work, we use the Shepp-Logan filter (see Figure 2.3), which is a combination of the ramp with
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a cardinal sine function. The Shepp-Logan filter transfer function HSL is defined as
HSL(ω)= |ω|sinc(ω). (2.26)
(a) (b) (c) (d)
Figure 2.4 – Main steps of the filtered back-projection algorithm. (a) Multiple line integrals
from a specimen section are acquired. (b) Each line integral is placed in the columns of a
matrix called a sinogram. (c) The sinogram is filtered column by column in the Fourier domain
with a ramp. (d) The back-projection of the filtered sinogram results in a sharp reconstruction
of the specimen section.
The given description of the FBP algorithm holds for X-ray CT with parallel beams. In Sec-
tion 2.2, I explain how OPT differs from CT. Then, I discuss how the optical projections are
realized and what consequences they have on the sample preparation. Finally, I introduce the
requirements that allow us to use the FBP algorithm with optical projections.
2.2 Optical projections
The essential difference between X-ray CT and OPT is the source radiation spectrum. In
OPT, it is the visible light spectrum (400-700 nm). Working with visible light is usually safer
than X-rays, and it is less cumbersome to manipulate. On the other hand, it has a shallower
penetration depth in tissues, around 10-20 µm [12]. To enhance the penetration depth in
opaque and semi-transparent samples, such as rodent organs, optical clearing methods are
needed [77]. There are two fundamental ways of generating optical projections with visible
light.
First, white light can be shined through the sample and detected on a camera with appropriate
imaging optics. This is known as the absorption mode of OPT (Figure 2.5(a)). In this mode,
light is absorbed in a different amount by the tissues it has to traverse following a Beer-Lambert
law. Depending on the tissue thickness and density, various shades of gray will appear on
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the detector with a white background where no absorption occurs. Similarly to X-ray CT, the
absorption mode of OPT is intrinsically unspecific. There exist some ways of staining the
samples which can give additional contrast in the projections [9], but these are not commonly
used.
This lack of specificity brings us to the fluorescence mode of OPT (Figure 2.5(b)). In this mode,
an excitation beam is shined orthogonally to the detection optics to trigger the fluorescence of
a marker or the endogenous tissue fluorescence. The fluorescence signal is then recorded on
the detector. The resulting projection is mostly dark with bright regions where the fluorophores
are. The fluorescence mode of OPT can be combined with the multitude of fluorescent markers
that exist among the life science community. In the remainder of this work, I will concentrate



















Figure 2.5 – The different operating modes of OPT. (a) In transmission OPT, white light is
shined through the sample. Dense tissue regions absorb a significant amount of light and
result in lower intensity values on the detector. (b) In fluorescence OPT, excitation light
is generally shined on the side of the sample to generate a fluorescent signal from tissues
(autofluorescence) or specific markers. The higher the fluorescence signal, the higher the
intensity values on the detector.
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Then, I want to give a few words on the imaging optics and what is needed to be able to use the
FBP algorithm in OPT. First, the depth of field (DOF) need to be equivalent to the maximum








where n is the surrounding medium refractive index, λ the emission wavelength, e the pixel
size in the detector plane, M the system magnification, and NA the numerical aperture of the
system. In this definition, we observe that the DOF inversely depends on NA. However, we
also know that the resolution of an optical system, which can be defined by the Airy radius r ,
depends on NA as
r = λ
2 ·NA . (2.28)
Therefore, to reach a certain DOF, the resolution has to be reduced (the value of r increases).
In practice, the loss of resolution is mitigated by keeping only the front part of the specimen in
focus while rotating over 360◦ instead of 180◦.
Second, we need to conserve the system magnification throughout the detection axis. This
property of optical systems is known as telecentricity. It guarantees that two objects of the
same size will appear with the same size on the detector independent of their position along
the detection axis. Our eyes, for example, are not telecentric. If we see two people at a different
distance from us, the person farther will appear smaller. This is not desirable in OPT as we
want to have a strict representation of our sample with constant magnification. Telecentricity
is achieved by having the image of the system aperture located at infinity. However, even with
perfect telecentricity and sufficient DOF, artefacts might still arise in OPT images.
2.2.1 Image artefacts
We will now discuss some of the relevant image artefacts that might arise in fluorescence OPT
images based on the work of Walls et al. [79].
First, the stability of the light source is a considerable cause of image artefacts in OPT (see Fig-
ure 2 in the work of Walls et al. [79]). While a majority of fluorescence OPT system use mercury
arc gas discharge lamps, some designs take advantage of light emitting diodes (LEDs) [80].
LEDs generally have better stability, and fluctuations are avoided by using quality power
supplies [81].
Second, photobleaching can cause a signal decay over the acquisition of multiple projections
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(Figure 3 in the work of Walls et al. [79]). This decay can be corrected by multiplying each
projection by a correction factor corresponding to the exponential decay. However, this also
causes an increase in the noise level.
Third, individual pixel variations in photon response can cause ring artefacts (Figure 2.6(a)). In
the worst case, “bad” pixels will always take the maximum or minimum value of the detector
dynamic range causing white and black rings to appear in the reconstructed image. Ring
artefacts can be reduced by applying a median filter to each projection, also decreasing the
resulting imaging resolution (Figure 2.6(b)).
(a) (b)
Figure 2.6 – Illustration of ring artefacts caused by pixel-to-pixel variations in photon response.
(a) Original OPT reconstruction of a mouse brain highlighting the characteristic circles em-
anating from the center of the image. (b) Result of the apodization of the ring artefacts by
applying a median filter to each projection.
Lastly, precise knowledge of the position of the center of rotation is essential to perform
accurate reconstructions of the specimen. This can be done by iteratively applying the FBP
with different centers of rotation and each time trying to maximize the reconstructed image
variance [82]. This procedure has a sub-pixel accuracy and guarantees a good reconstruction
quality. However, multiple reconstructions of the same image have to be performed which is
time-consuming and requires sufficient computer power.
2.3 Practical aspects
OPT imaging of whole mouse organs is often performed ex vivo [47, 50]. To extract the
organs, the mouse is deeply anesthetized, and an operation called “transcardiac perfusion”
is performed [83]. To put it briefly, after verification of the depth of anesthesia using the toe
pinch-response method, precise incisions in the abdominal wall give direct access to the
heart. The needle of a perfusion apparatus (usually syringes and valves) is inserted in the
left ventricle, and another incision is made in the right atrium. Several milliliters of a buffer
solution is perfused through the heart to wash away the blood, significantly reducing the
tissue autofluorescence during imaging later. Then, a few more milliliters of a fixation solution
is perfused to fix the whole mouse in a life-like state. Finally, the organs can be harvested
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following a protocol such as the one by Antal et al. [84]. In this work, we mainly harvested the
mouse brain, kidney, and lung but most organs can be acquired with an OPT instrument if the
magnification is adapted.
In medical CT scanners, the patient is placed on a table. Then, the source and detector are
rotated around the patient to acquire the projections. In OPT, it is simpler to have the source
and detector fixed while the specimen is turned, because of its size (few centimeters). The
sample is firmly attached to a motorized rotation stage with glue [85, 86]. However, direct
contact with glue would damage the sample. Therefore, mouse organs are mounted in an
agarose gel. The gel is poured in a large petri dish with the organ, and after it cooled down, a
small block containing the specimen is trimmed away.
Light penetration in mouse organs is limited to few tens of micrometers [12]. Therefore,
an additional clearing step is necessary to make tissues semi-transparent in view of OPT
acquisition. There exists a variety of clearing techniques [77], but one of them stands out by
its simplicity and reliability in whole mouse brain preparation. This technique consists in the
dehydration of the sample in ethanol for 7 days and rehydration in a 1:2 solution of benzyl
alcohol and benzyl benzoate (BABB) for 2 days [33].
Finally, the last step before OPT acquisition and FBP reconstruction is to choose a num-
ber of projections which also determines the angular increment of the motor. Originally,
400 projections were used [9], and more recently, 1200 projections were tried in the mouse
brain [50].
In Chapter 3, we discuss how to implement an OPT instrument with a specific resolution and
DOF for large specimen (in the order of a few centimeters), while guaranteeing telecentricity.
Additionally, we introduce a means of retrieving the center of rotation based on convolution
between mirrored projections (separated by 180◦), and an optimized clearing protocol for
whole mouse brains that last approximately 3 days. We also showcase whole mouse brain
images of the neuroanatomy, vasculature and amyloid plaques in a model of AD. Moreover, in
Chapter 4, we present a series of improvements of the practical aspects of OPT.
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The design of custom optical projection tomography instruments (OPT) [45, 51] allows the
exploration of new biomedical imaging applications. In neuroscience, custom OPT instru-
ments are used for neuroanatomical phenotyping of the mouse brain [50], based on tissue
autofluorescence. A next step to explore in this domain is the potential application of OPT to
the study of neurodegenerative diseases. In this work, a custom OPT instrument was designed
for 3D whole-mouse brain imaging with fluorescent markers of vasculature and amyloidosis,
the latter being a hallmark of Alzheimer’s disease. It features a 17 cm3 imaging volume with
50 µm resolution and epi-fluorescence illumination using light emitting diodes (LEDs).
Moreover, this OPT instrument has been duplicated at Lund University and is applied to
the study of autoimmunity in the research group of Professor Dan Holmberg (also available
to other users in the university through the OPT imaging platform web page [87]). The
instrument design and underlying sample preparation protocols are the topics of a research
article published in Biomedical Optics Express in 2017 [55] (doi: 10.1364/BOE.8.005637). The
rest of this section is composed of the postprint version of the article, followed by a detailed
list of author contributions.
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Abstract
In recent years, three-dimensional mesoscopic imaging has gained significant importance
in life sciences for fundamental studies at the whole-organ level. In this manuscript, we
present an optical projection tomography (OPT) method designed for imaging of the intact
mouse brain. The system features an isotropic resolution of ~50 µm and an acquisition time
of four to eight minutes, using a 3-day optimized clearing protocol. Imaging of the brain
autofluorescence in 3D reveals details of the neuroanatomy, while the use of fluorescent labels
displays the vascular network and amyloid deposition in 5xFAD mice, an important model of
Alzheimer’s disease (AD). Finally, the OPT images are compared with histological slices.
Introduction
Since its invention in the 19th century, histopathology has been and continues to be a widely
used method for tissue-based medical diagnosis. While it excels at producing two-dimensional
images of tissue sections, extracting information from whole three-dimensional tissues re-
mains challenging. As a complement to histopathology, a new imaging regime, termed
mesoscopy [12] emerged at the beginning of the century for 3D visualization of samples
spanning a scale from a few millimeters to several centimeters. Over time, various techniques
have been developed within this regime.
Micro-optical sectioning tomography (MOST) [88] is a block-face imaging method where the
process of histology is automatized via simultaneous imaging and sectioning of the tissue. This
technique has been successfully applied to image a whole mouse brain with a submicrometric
resolution [89]. However, the acquisition time of approximately two weeks represents an
experimental limitation for studies involving numerous animals.
Light-sheet microscopy [90] is probably the most prolific example of these mesoscopic tech-
niques. Light-sheet microscopy performs three-dimensional imaging by scanning an engi-
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neered sheet of light orthogonal to the optical axis. This illumination mechanism achieves
optical sectioning without slicing the tissue along with minimal photobleaching. The penetra-
tion depth of light-sheet microscopy is enhanced in naturally-transparent or cleared samples
due to the reduction in light scattering. Recent research on light-sheet microscopy has mainly
been focused on in vivo imaging. Improved illumination strategies (for example with optical
lattices [35]), and solutions for specimen mounting in a physiological environment [40] have
been developed. Additionally, the combination of light-sheet microscopy with structured illu-
mination microscopy has increased the visibility through opaque samples [41], thus avoiding
optical clearing (a process often done ex vivo due to its toxicity). Efforts have also been directed
towards imaging larger samples, such as entire neural [33] and vascular networks [91, 92], or
Alzheimer’s disease (AD) hallmark amyloid deposition [43] in whole mouse brains. These par-
ticular results have helped to establish light-sheet microscopy as a tool for mouse phenotyping
and investigations of disease models. Light-sheet microscopy produces outstanding 3D image
quality with subcellular resolution over large volumes, which typically translates into big data
sets. These require excessively long image processing time and terabytes of data handling [93].
Moreover, the optical design and image processing pipeline of such systems can be complex
for inexperienced users. For these reasons, we propose optical projection tomography (OPT)
as an alternative.
OPT is a three-dimensional imaging technique developed by James Sharpe in 2002 [9] for 3D
microscopy and gene expression studies. Considered as an optical analogue of X-ray com-
puted tomography (CT) [73], OPT allows sample reconstruction from projections acquired
at different angles. These projections are images taken over 360◦, by rotating the sample,
with a depth of field (DOF) covering half the specimen. Depending on the illumination, the
projections either provide information on the light absorption or the integration of a fluores-
cence signal through the sample [44]. In both cases, the reconstruction of inner structures
strongly depends upon the sample’s transparency. For enhanced penetration depths, OPT
requires naturally-transparent or cleared samples. Recently, custom OPT systems have been
developed [45], including helical OPT [51], where a vertical translation is introduced dur-
ing the acquisition process to enable imaging of elongated samples, such as rodent spinal
cords and large intestines. Along with these hardware improvements, OPT benefited from
several artifact-correction [79] and resolution improvement [94] algorithms. For example,
to automatically recover the center of rotation (COR) in the projections [82] or to account
for fluorescence absorption in tissues with a normalized Born approach [95]. Additionally,
accelerated reconstruction procedures have been achieved by taking advantage of either
iterative algorithms [96], or parallel processing on the graphics processing unit (GPU) [97].
Various applications highlight the performance of OPT. These include in vivo imaging of
the zebrafish vasculature [46], fruit fly pupae head eversion process [98], morphogenesis of
salivary glands and wing imaginal discs [99], as well as fluorescence lifetime in living zebrafish
embryos [100], and visualization of plant development [101, 102]. Furthermore, OPT has
been used for whole organ imaging in mice to study the pancreas and beta-cell tissue in
the development of diabetes [48, 49], the spinal cord and optic nerve in the development of
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experimental autoimmune encephalomyelitis (EAE) [103], and to perform neuroanatomical
phenotyping [50, 104]. So far, OPT is limited in resolution by the depth of field required for
imaging. However, its rapidity and simplicity in image acquisition and processing make OPT
convenient for various routine applications.
In this paper, we present a novel OPT methodology for whole mouse brain imaging. It includes
an OPT design which uses the principle of epifluorescence, a feature known to maximize the
rejection of stray light and homogenize the illumination in the sample plane. In addition
to the setup design, we provide an outline of the software processing and demonstrate 3D
imaging of the brain with an optimized solvent-based clearing protocol. A dehydration step
of a single day in 100 % methanol with one refresh in the clearing protocol is shown to be
sufficient to reveal details of the mouse neuroanatomy (while several days and increasing
concentration of solvent solution were previously required [33, 43, 50]). Furthermore, our
sample preparation has been successfully combined with different standard labeling protocols
from fluorescence imaging technology to image the vasculature of wild-type mouse brains
as well as the distribution of amyloid plaques in the brain of transgenic mice that coexpress
five familial AD mutations (5xFAD mice) [105], an important model of the disease. Finally, we
show a comparison of the OPT images with histological slices from the same mouse brain.
Materials and methods
Optical Projection Tomography
Our mesoscopic OPT setup (Figure 3.1) is designed for 3D imaging of whole intact mouse
brains. As shown in blue in Figure 3.1(A) and 3.1(B), the detection arm consists of a 4f sys-
tem with an objective lens Lo (f = 300 mm, AC508-300-A-ML, Thorlabs) and a tube lens Lt
(f = 150 mm, AC508-150-A-ML, Thorlabs), both achromatic. This configuration results in
a 0.5X magnification on the detector (ORCA-Flash 4.0 V2, Hamamatsu), providing a field
of view (FOV) of 26.6 × 26.6 mm2 over 1024 × 1024 px2 in a 2 × 2 binning mode (initially
2048 × 2048 px2). A DOF of approximately 15 mm (according to the definition of Inoué and
Spring [106], equation 2.18) is obtained by placing a 4 mm diameter diaphragm in the rear focal
plane of the objective lens, which also makes the system telecentric. The resulting numerical
aperture (NA) of 0.01 provides a diffraction-limited lateral resolution of 28 µm (according to
the definition of Inoué and Spring [106], equation 2.7). However, this diffraction-limited lateral
resolution is currently hindered by the pixel-limited resolution of 52 µm (twice the binned
pixel size). The projections are captured at angular steps of 0.3◦ (or 0.9◦ in Figure 3.6(E)) by
rotating the sample over 360◦ i.e., 1200 projections (or 400 projections in Figure 3.6(E)), in a
step-and-shoot mode. The reconstruction of samples as thick as 26 mm (limited by the FOV) is
typically achieved within minutes (see Table 3.1 for details on exposure and acquisition time).
As illustrated in green in Figure 3.1(A), the sample is illuminated by switchable LEDs. In this
manuscript, we use a 420 nm LED (M420D2, Thorlabs) and a 470 nm LED (M470D2, Thorlabs),
also described in Table 3.1. These LEDs are collimated by an aspheric lens Lc (f = 16 mm,
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ACL25416U, Thorlabs). The resulting illumination beam is magnified by another 4f system
composed of an achromatic relay lens Lr (f = 150 mm, AC254-150-A-ML, Thorlabs) and the
objective lens, providing a uniform full-field illumination of the sample plane while maximiz-
ing the rejection of stray light. A kinematic fluorescence filter cube (DFM1/M, Thorlabs) is
used to introduce and filter the illumination beam in the detection path (epifluorescence),
and a modular LED switching mechanism (Figure 3.1(C)) allows the user to choose between
different fluorescence configurations (described in Table 3.1).
Table 3.1 – OPT configuration to visualize different features of interest. Stated are LEDs, filters,
exposure time, and total acquisition time. Filters references are from Chroma: EX, excitation
























Before imaging, the sample embedded in agarose is glued (Loctite 454, Loctite) on a holder
and attached to a motorized rotation stage (8MR190-2, Standa) using a magnet, as depicted in
Figure 3.1(D). The OPT imaging takes place across a cuvette (704-001-30-10, Hellma Analytics)
filled with a 1:2 mixture of benzyl alcohol and benzyl benzoate (BABB) for index matching.
Three motorized linear stages (8MT167-100, Standa) provide additional degrees of freedom for
aligning and focusing the sample. We use the translation along the y-axis to align the rotation
axis on the center of the detector, and the magnet to align the sample gravity center on the
rotation axis. These alignment procedures are necessary to keep the sample within the FOV
of the setup but can be carried out approximately since the COR is numerically retrieved in
the reconstruction algorithm. The tilt of the rotation axis has been minimized by precisely
manufacturing the custom components and does not significantly affect the reconstruction
process. More control on this parameter can be achieved by adding a tip-tilt mount on the
rotation stage and using the alignment protocol described by Wong et al. [45].
Image Processing
As illustrated in Figure 3.2, image acquisition with the OPT system produces a stack of 1200 or
400 projections, separated by the same angular distance and depicting the sample over 360◦.
These projections are pre-processed with Fiji [107] depending on the sample preparation.
Brain autofluorescence reconstructions sometimes present ring artifacts [79], presumably due
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Figure 3.1 – OPT design. The optical layout (A) and the corresponding CAD rendering (B)
illustrate the detection (blue) and illumination (green) arms. A detailed view of the LEDs
mount (C) demonstrates the system for alignment and switching. It is composed of a custom
heat sink (yellow), a spring (red, C.254.250.0250.A, Vanel), and a ring (blue, SM1RR, Thorlabs)
stacked inside a 1-inch tube (SM1L20, Thorlabs) and screwed to a quick-release translation
mount (CXY1Q, Thorlabs). The custom sample holding mechanism (D) consists of a base
tube (yellow) glued to a magnet (green) to hold the magnetic stainless steel cylinder (red). The
sample is glued to the blue cylinder which can be screwed to the whole mechanism.
to a variation in the pixels response of the camera. A median filter (3 × 3, radius 0.5 px) is
applied to the projections to mitigate this effect. Vasculature-labeled brain reconstructions
display an increased contrast by applying a mean filter of the same size to the projections.
No pre-processing step is applied to amyloid-labeled brain projections. A line is fit on the
maximum values of the convolution of the first projection I0◦ with the opposite projection
I180◦ along the vertical direction. This line forms a vector containing the CORs (shown with a
green dotted line in Figure 3.2), for each vertical position in the projection stack. These COR
values are crucial to avoid artifacts in the reconstruction. The projection stack is transformed
into a sinograms stack, by permuting the dimensions of the stack, and each sinogram is
high-pass filtered with a Shepp-Logan filter. A 3D image of the sample is obtained by back-
projecting each sinogram around the corresponding COR value with a linear interpolation. The
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sinograms’ filtering and back-projection compose the conventional filtered back-projection
(FBP) algorithm [73] and are implemented in CUDA (Nvidia) to take advantage of massive
parallelization on the GPU. A desktop computer operated with Windows 7 Enterprise SP1
64-bit (Microsoft) and equipped with two Xeon CPU E5-2650 v2 (Intel), 64 GB DDR3 RAM, a
GeForce GTX TITAN Black embedding 2880 CUDA cores, and 6 GB GDDR5 memory allows
processing the samples in approximately 2 minutes for a resulting 8-bits stack of 1024 × 1024
× 1024 px3 (around 0.5 GB in size). Finally, three-dimensional image rendering is performed































Figure 3.2 – Image processing pipeline illustrating the filtered back-projection (FBP) as well as
the automatic retrieval of the COR algorithms. After a pre-processing step (described in text),
the sinograms are filtered and the corresponding COR is retrieved. Following these operations,
the sinograms are back-projected to form the virtual tissue sections, and 3D rendering is
applied.
Mouse Model
5xFAD genetically-modified mice [105] were purchased from The Jackson Laboratory on a
congenic C57BL/6J background (34848-JAX, MMRRC). They were bred and maintained in-
house with SJL/J mice (000686, The Jackson Laboratory) to generate the experimental animals
on a hybrid B6SJL F1 background, which demonstrates a more robust amyloid phenotype. This
model of AD is extensively used in research and displays many of the phenotypes associated
with the disease [105]. In particular, the mice are known to develop an early and severe amyloid
deposition starting from 1.5 months of age [105].
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Sample Preparation
All animal procedures were carried out according to Swiss regulations under the approval of
the veterinary authority of the canton of Vaud.
Amyloid plaques labeling. Similar to the protocol reported by Jährling et al. [43], 5xFAD
mice and their littermate controls, on a B6SJL F1 background, received two consecutive
intraperitoneal (IP) injections of 30 mg/kg Methoxy-X04 (Tocris) in DMSO (10 mg/ml) with a
24-h interval. During the second injection, 100 µl (30 µg/ml) buprenorphine in 0.9 % NaCl was
also administered subcutaneously (SC) for analgesia. Two hours later, the animals were deeply
anesthetized IP with sodium pentobarbital (150 mg/kg) in aqueous solution (150 mg/ml).
Once the depth of anesthesia was sufficient (assessed with toe pinch reflex), the animals were
transcardially perfused with 2 ml of heparinized (5 I.U./ml) 1X PBS (pH 7.4), followed by 15 ml
of 10 % formalin solution (HT501128, Sigma), at 4◦ C and 1.5 ml/min, for tissue fixation. After
the perfusion, the brains were extracted and postfixed in 40 ml of formalin at 4◦ C overnight.
Vasculature labeling. B6SJL F1 mice were anesthetized as described above (including the
injection of buprenorphine). Subsequently, an identical transcardial perfusion was performed
with the additional 10 ml of hydrogel [92] at 40◦ C and 1.5 ml/min. The hydrogel is a mixture
of 2 % (w/v) gelatin (G1890, Sigma) in 1X PBS (prepared at 60◦ C) and 0.1 % (w/v) FITC-
conjugated albumin (A9771, Sigma) done at 40◦ C (0.22 µm-filtered). Before organ harvesting
and fixation (as described above), the mouse head was incubated in ice-cold water for 10
minutes to solidify the hydrogel.
Organ clearing. After fixation, the organs were mounted in 1.5 % (w/v) agarose (16500500,
Invitrogen) at 45◦ C with Milli-Q water (0.22 µm-filtered and degassed) and dehydrated in
40 ml of 100 % methanol (ME03161000, Scharlau) on a rotator (10 RPM) for 24 h with a renewal
of the methanol after 15 h. Similar results (not shown here) were obtained by dehydration
in ethanol. Then, the organs were transferred to a 40 ml solution of BABB (148390010 and
105860010, ACROS Organics) for optical clearing. This process can last for several days, but
after approximately 48 h, the brain transparency is sufficient for imaging.
Histology. After fixation, the brains were split into hemispheres. One hemisphere was cleared
and imaged with OPT. The other hemisphere was transferred to a 40 ml solution (0.22 µm-
filtered) of 30 % (w/v) sucrose in 1X PBS (pH 7.4) at 4◦ C for approximately 48 h, or until
the sample sunk at the bottom of the tube. Then the sample was partially dried on a tissue,
placed in an embedding mold (such as 27112, Ted Pella Inc), and immersed in Cryomatrix
(6769006, Thermo Scientific). Following the immersion in Cryomatrix, the mold was dipped in
a bath of isopentane (avoid contact between Cryomatrix and isopentane) and dry ice until the
Cryomatrix became completely opaque. Afterwards, the samples were stored at -80◦ C before
slicing, with a sliding microtome, and mounting. The hemisphere sections were imaged on
an Apotome (Zeiss) with a 5X, 0.15 NA air-objective, as well as a DAPI and wtGFP filter sets
(for plaques and vasculature respectively). The Fiji plugin MosaicJ [108] was used to stitch the
Apotome images together and create an image of the whole section.
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Results and discussion
Neuroanatomy
To demonstrate the performance of our novel OPT approach, we started by clearing 2- to
8-month-old B6SJL F1 mouse brains (n>5). Figure 3.3(A) shows a representative image of a
cleared brain at the age of 8 months. The transparency is sufficient to see through the organ and
is adequate for OPT imaging (see Figure 3.3(B) and 3.3(C)). Standard BABB clearing techniques
require tissue immersion in increasing series of methanol concentration for dehydration to
prevent cellular distortions and excessive shrinkage of the tissue. However, we found that it is
not needed for OPT as the agarose embedding acts as a protective coating. The samples are
directly dehydrated in 100 % methanol, and this simplifies the clearing protocol. Although
not shown in Figure 3.3, we observed shrinkage of the organs, a known side-effect of BABB
clearing [109].
Images of the same 8-month-old brain were further acquired using the OPT system with the
420-nm excitation illumination, and a 3D rendering is shown in Figure 3.3(B). With its 0.5X
magnification and 15-mm DOF, the setup successfully captures the whole three-dimensional
nature of the organ. Individual coronal sections (Figure 3.3(C)) reveal details of the neu-
roanatomy down to the deepest structures. For example, the lateral (vl) and third (v3) ventri-
cles are cavities in the brain, which get filled with BABB and therefore appear as dark regions
in the sections. The caudoputamen (cp), identified through its sponge-like structure, and the
thalamus (th), appear brighter. More brain regions can be identified via the different autofluo-
rescence contrasts, such as the cortex (ctx), culmen (cul), and medial mammillary nucleus
(mm), which present a higher contrast, the optic chiasms (och), which appear as a bright tube
with a dark, presumably hollow, core, but also the corpus callosum (cc), the hippocampal
region (hip), the inferior colliculus (ic), and the central lobule (cent). The identification of
these different brain regions using the autofluorescence contrast confirms the ability of our
OPT system to perform neuroanatomical phenotyping as described previously [50].
Vascular network
Vascular abnormalities play an important role in cognitive decline and inflammation in some
AD patients. To demonstrate the compatibility of our clearing protocol with a fluorescence
labeling of the vasculature, we perfused the animals with an FITC-albumin hydrogel. This
labeling method was performed on 4-month-old B6SJL F1 mouse brains (n=2) and the resulting
images, acquired using the OPT system with the 470-nm excitation illumination, are shown in
Figure 3.4. In this configuration, we can identify a variety of vascular compartments, including
the superior sagittal sinus (SSS) and the sigmoid sinus (SS), which are venous sinuses found
within the dura mater, the outermost layer surrounding the central nervous system, and
located on top of the brain (Figure 3.4(A)). The caudal rhinal vein (CRV), running on the side
of the brain in a sagittal manner (Figure 3.4(B)), the anterior cerebral artery (ACA), which
partly forms the circle of Willis, ring-shaped system of arteries, situated at the base of the
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Figure 3.3 – Photograph of a mounted and cleared 8-month-old B6SJL F1 mouse brain (A).
3D rendering of the OPT image obtained from tissue autofluorescence (B, Visualization 1
[available online]). Single coronal sections of the OPT image (C) showing the inner morphology
of the intact organ: cc, corpus callosum; cent, central lobule; cp, caudoputamen; ctx, cerebral
cortex; cul, culmen; hip, hippocampal region; ic, inferior colliculus; mm, medial mammillary
nucleus; och, optic chiasm; p, pons; th, thalamus; v3, third ventricle; vl, lateral ventricle. Grid
spacing (in A): 1 cm. Scale bars: 1 mm.
brain (Figure 3.4(C)), and the middle cerebral artery (MCA) traveling from the circle of Willis
to the top of the brain. To better appreciate the 3D nature of the blood vessels, we created
maximum intensity projections from 20 consecutive OPT sections at different positions of
the brain (Figure 3.4(D)). These artificial sections represent half a millimeter of the whole
brain sliced coronally and highlight penetrating vessels several millimeters in depth. However,
smaller vessels, such as capillaries, have a diameter of typically less than 10 µm and fall beyond
our resolution limit. The innermost vessels of the brains are seemingly undetected. This
could be due to the depletion of the fluorescence signal propagating through the sample as
well as the shadowing from the surface vasculature. Ultimately, the identification of large
brain vessels with the hydrogel perfusion extends the phenotyping capacity of OPT and has
potential application in the study of aneurysms, strokes, and vascular development [110].
Amyloid deposition
New amyloid imaging agents, based on the chemical structure of histologic dyes, are now
making it possible to track amyloid pathology along with disease progression. To show the
compatibility of our clearing protocol with fluorescence labeling of amyloid deposits, we
injected the animals IP with an amyloid-binding dye called Methoxy-X04. This labeling
method was performed on 8-month-old 5xFAD mouse brains (n=3) and the resulting images,
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Figure 3.4 – Visualization of the brain vasculature in a 4-month-old B6SJL F1 mouse. The
brain was perfused with an FITC-albumin hydrogel and imaged with OPT. 3D rendering from
the top (A), side (B), and bottom (C) view (see Visualization 2 [available online]). Maximum
intensity projections of 20 coronal sections through the whole brain (D) showing the penetrat-
ing venules/arterioles. ACA, anterior cerebral artery; CRV, caudal rhinal vein; MCA, middle
cerebral artery; SS, sigmoid sinus; SSS, superior sagittal sinus. Scale bars: 1 mm.
acquired using the OPT system with the 420-nm excitation illumination, are shown in Fig-
ure 3.5. Individual sections of the three-dimensional OPT image (Figure 3.5(A)) reveal a mixed
contrast between the brain anatomy and amyloid plaques, seen as bright dot agglomerates
(denser zones pointed out by the arrows), caused by the overlap of the autofluorescence
and the Methoxy-X04 emission spectra. The 3D rendering of the whole brain, presented in
Figure 3.5(B), reveals the amyloid distribution in the organ and highlight an important aggre-
gation in the subiculum (Figure 3.5(B) and 3.5(C)). This result adds to the findings of Oakley et
al. [105], who used histology to localize amyloid deposition, providing deeper insights into the
3D distribution of the amyloid plaques. Interestingly, the pathological phenotype observed in
the 5xFAD mice shows differences in the 3D distribution compared to the APPPS1 model used
in the work of Jährling et al. [43] at a comparable age. This observation further demonstrates
the high potential of OPT for fast phenotyping. Small plaques (below 50 µm) are blurred out
due to the system’s resolution.
Histology comparison
The proposed framework for rapid mouse brain imaging with OPT extends the current 3D
capability of traditional histology. For this reason, we performed a qualitative comparison of
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A B C
Figure 3.5 – 3D imaging of amyloid deposition in an 8-month-old 5xFAD mouse. Single coronal
sections (A) with the arrows pointing to regions with high deposition and three-dimensional
rendering of the OPT image (B, Visualization 3 [available online]). A 3D image of the subiculum
(green) is shown within a whole mouse brain (C) to compare with the location of amyloid
deposition. Image (C) was obtained from the Allen mouse brain atlas [111]. Scale bars: 1 mm.
both techniques by splitting labeled mouse brains into hemispheres. The hemispheres were
then processed separately: one was prepared for histology (Figure 3.6(A) and 3.6(D)), and the
other one for OPT (Figure 3.6(B)-(C) and 3.6(E)).
First, the result of this comparison for the vasculature in a 9-month-old B6SJL F1 mouse brain
is shown in Figure 3.6(A)-(C). The histological slice (Figure 3.6(A), Visualization 4 [available
online]) displays details of the microvasculature as well as larger vessels, pointed by pink
arrows. However, the acquisition and stitching of the images took almost an hour for a single
section. Additionally, stitching artifacts, such as the one pointed by the blue arrow, remain
visible in the figure. On the other hand, some of the large vessels (pink arrows) can be identified
in the OPT section (Figure 3.6(B)), but the microvasculature is not resolved. Additionally, we
used the 3D capability of OPT to produce a maximum intensity projection (Figure 3.6(C)) from
20 consecutive sections (approx. 0.5 mm in thickness), which reveals a range of penetrating
vessels otherwise difficult to obtain in histology.
Second, the result of the comparison for the amyloid plaques in a 3-month-old 5xFAD mouse
brain is shown in Figure 3.6(D)-(E). The histological slice (Figure 3.6(D), Visualization 5 [avail-
able online]) present a high-resolution mixed contrast between tissue autofluorescence and
amyloid plaques (regions of accumulation pointed by green arrows). However, the acquisition
and stitching took approximately an hour, and the resulting section suffers from microtome
artifacts (blue arrows). On the other hand, the regions of plaques accumulation (green arrows)
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could be retrieved in the OPT section (Figure 3.6(E)) with a lower resolution. Additionally, we
observed an opposed contrast in some regions of the brain, such as the corpus callosum (cc),
which is bright in the histological section but appears dark in OPT. This might be caused by
the chemical clearing.
These results highlight the complementarity of traditional histology and OPT. Mechanical
slicing associated with wide-field fluorescence microscopy produces high-resolution images
of the features of interest in 2D. However, this method can be cumbersome (particularly the
cutting and stitching parts) and is hardly suitable for 3D imaging. On the other hand, OPT





Figure 3.6 – Comparison of histological and OPT slices. 40 µm-coronal section of a 9-month-
old B6SJL F1 mouse brain hemisphere labeled for vasculature (A, Visualization 4 [available
online]) and corresponding single OPT section (B). A maximum intensity projection (C) taken
over 20 consecutive OPT sections, which represents approximately 0.5 mm in thickness, gives
a better representation of the penetrating vessels and highlights the 3D advantage of this
technique. 40 µm-coronal section of a 3-month-old 5xFAD mouse brain hemisphere labeled
for plaques (D, Visualization 5 [available online]) and corresponding single OPT section (E),
some regions such as the corpus callosum (cc) show an inverted contrast. Scale bars: 2 mm.
Conclusion
In this manuscript, we present a novel OPT method for whole mouse brain imaging. This
method is based on a custom OPT system, designed for mouse brain imaging, and an opti-
mized sample preparation. The OPT system provides an FOV of 26.6 × 26.6 mm2 and can
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image samples as thick as 26 mm typically within less than 5 minutes. It incorporates an
epifluorescence arm, which provides a uniform full-field illumination and is easily config-
urable by switching the excitation LEDs and filters. The sample preparation consists of a
simple and rapid solvent-based clearing of the organ (3 changes of clearing solution in 3 days).
This can be complemented with fluorescence labeling of the vasculature, through perfusion
of a fluorescent hydrogel, or labeling of amyloid deposition in a mouse model of AD, via 2
consecutive injections of an amyloid-binding dye. Based on this method, we imaged B6SJL F1
mouse brains without markers. The results demonstrate the quality of the clearing and reveal
details of the organ structure, an essential requirement of neuroanatomical phenotyping [50].
Additionally, by imaging the vasculature of B6SJL F1 mouse brains, we identify major vessels,
as well as penetrating arterioles/venules in 3D down to several millimeters in depth. We also
imaged 5xFAD mouse brains with labeled amyloid deposition. Individual sections of the OPT
image revealed regions of accumulated amyloid plaques. Through 3D rendering, we could
identify the subiculum as the region with the densest accumulation, in concordance with the
literature [105]. Finally, we performed a qualitative comparison of histological and OPT slices
in the different hemispheres of the same brain to illustrate the complementarity of these two
techniques.
The rapid acquisition of whole mouse brains with our OPT system is achieved through a long
DOF and a low magnification, which currently limit the resolution to ~50 µm. Additionally,
the low NA of the system restricts the light collection efficiency. This would be a plausible
explanation for why finer structures such as capillaries and small amyloid plaques (<50 µm)
were undetectable. Furthermore, the method requires embedding of the sample in agarose
for mounting purposes. While the surrounding agarose simplifies the clearing protocol, by
creating an interface with the solvents and avoiding the use of increasing concentration
solutions, it has not been tested yet with other clearing methods such as CLARITY [112],
SeeDB [109], Scale [113], or 3DISCO [114].
In the future, other clearing methods optimized for OPT might improve the current results
obtained with BABB; new amyloid imaging agents with a distinct excitation/emission spec-
trum will help to discriminate between the tissue autofluorescence and the amyloid plaques.
Additionally, our imaging method shows high potential for the use in neuropathology and
the study of disease progression, similarly to the work and research in diabetes [48, 49], by
imaging the mouse pancreas at different ages. Ultimately, our OPT setup with its large FOV is
well suited for the imaging of other organs, such as the liver, lung, and kidney.
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4 OPT optical and tomographic instru-
ment characterization
In the previous chapter (Chapter 3), the implementation of a custom OPT instrument for
mouse organ imaging was described. In parallel to the development of this instrument, we
contributed to the characterization of OPT instruments in various areas. First, we aimed
to standardize the mounting procedure to decrease sample preparation variability, which
we achieved by molding agarose in conical tubes. The new mounting procedure facilitates
sample preparation and is less prone to image artefacts, due to the agarose block shape
in the original procedure. Second, we performed microparticle imaging to understand the
instrument’s transfer function through its point spread function. This approach to characterize
the instrument has rarely been applied in standard OPT, and our results suggest that it is
relevant to perform it on every instrument at least once because it can reveal imperfections
in the motorized rotation stage. Finally, ever since the introduction of OPT in 2002, the
choice of a number of projections for OPT acquisitions has never been discussed. It was
originally suggested to use 400 projections (separated by 0.9◦) [9]. Later, researchers worked
with empirical numbers such as 360 projections (separated by 1◦) [97] and 1200 projections
(separated by 0.3◦) [50], but without any justification on their choice. Although these number
of projections lead to good quality OPT images, we decided to challenge their empirical values.
The results suggest that the number of projections to be acquired depends on the type of
sample to be imaged and its spatial frequency content. Moreover, when evaluated in mouse
organs, the number of projections required to compute accurate reconstructions was always
higher than the original 400. These contributions are detailed in a research article submitted to
the Journal of Biomedical Optics in December 2018. This section is composed of the preprint
version of the article, followed by a detailed list of author contributions.
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Abstract
Optical projection tomography (OPT) is a mesoscopic imaging tool holding invaluable poten-
tial for life sciences, as the understanding of biological processes goes through 3D visualization
at the centimeter scale. We address key technical aspects of OPT to improve reconstructions
quality. An agarose embedding procedure based on molding in conical tubes is presented, and
images of fluorescent microparticles are shown. We also introduce a method to investigate
the effects of the number of projections on the reconstruction’s quality. All of this showcased
in different mouse organs endogenously and with a vasculature staining. We hope that these
insights will make OPT more accessible and that they will open the door to new applications
of mesoscopic 3D imaging.
Introduction
Mesoscopic imaging is a branch of optical microscopy focusing on large samples, typically
with a size ranging from a few millimeters to several centimeters in at least one direction [12].
The principal modalities of mesoscopic imaging include light sheet fluorescence microscopy
(LSFM), opto-acoustic (OA) microscopy, and optical projection tomography (OPT) [116]. These
methods have critical applications in life sciences and hold an invaluable potential to extend
the molecular and cellular knowledge to a higher level of structural organization. LSFM [90]
uses a planar illumination shined orthogonally to the detection axis to produce fluorescent
optical sections of a specimen and reconstruct 3D volumes. This method has been applied
to the visualization of neural [33], and vascular [91, 92] networks in whole mouse brains, as
well as the recording of neuronal activity in whole zebrafish brains [38] and the imaging of
the fruit fly nervous system [10]. OA microscopy [117] records optical absorption in tissues by
measuring pressure changes upon excitation with a light pulse. This method has been applied
for the visualization of the whole mouse [29] and zebrafish [118] anatomy. Lastly, OPT [9]
takes a series of in-focus images at different angles, called projections, over a complete turn
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to compute a 3D reconstruction of the specimen with a filtered back-projection algorithm
(FBP) [73]. OPT has been used since 2002 for 3D fluorescence imaging of biological specimen.
It was originally described as a tool for gene expression studies in mouse embryos [44], but its
field of application proliferated.
For instance, whole mouse pancreas imaging with OPT plays a key role in diabetes research [47,
48, 49], providing scientists with a quantitative overview of the disease progression in the
entire organ. Similarly, whole mouse brain imaging is performed with OPT for the study
of Alzheimer’s disease [55]. In vivo OPT imaging of zebrafish embryos [119, 100] can also
be applied to study the cardiovascular system [46]. Technological advances have closely
followed the application growth in OPT. Helical scanning [51] allows acquisition of elongated
samples, such as the mouse spine, without compromising the field of view. Normalized
born approach [95] has been proposed in fluorescence OPT to account for tissue absorption
properties. A point-spread-function based method to reconstruct OPT images increases
signal-to-background ratio and resolution [53, 54]. However, these features aim to improve
OPT resolution, and few papers have been dedicated to the fundamental aspects of OPT
imaging. These include investigations of the importance of correct determination of the
center of rotation [82], and correction of image artefacts in OPT [79], although the latter is
mostly restricted to simulation cases.
This work aims to consider other fundamental and recurring aspects of OPT acquisition and
to present preliminary studies highlighting interesting avenues for the future development of
OPT technology.
While standard OPT sample preparation protocols exist [85, 86], they rely on the critical
trimming of the sample-enclosing agarose block. As a means to uniformize sample shape
and reduce the risk of sample damage and imaging artefacts, we introduce a nearly cut-free
specimen embedding procedure in agarose via molding in conical tubes. Then, we rely on
imaging microparticles to qualitatively characterize the point spread function (PSF) of our OPT
instrument, to better understand imaging and reconstruction artefacts. Images of fluorescent
microparticles also illustrate the space-varying nature of the PSF in OPT. The last aspect we
study concerns an essential parameter of OPT acquisition, which is the number of projections.
It is well known in X-ray computed tomography that the number of projections plays a crucial
role in reconstruction accuracy [120], and that reconstruction from an insufficient number of
projections leads to heavy image artefacts. We investigate the influence of increasing the num-
ber of acquired projections on the resulting reconstruction quality in various samples, namely
the mouse brain, lungs, kidney, and fluorescent microparticles. The comparison between
specimen reconstructions from a different number of projections is based on correlations. To
the best of our knowledge, it is the first time that the effect of the number of projections is
investigated in OPT.
In Section 4.1, we review the OPT sample preparation and present our different specimen
embedding procedure. We describe the OPT instrument PSF qualitatively through the use
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of fluorescent microparticles in Section 4.1. Finally, in Section 4.1, we present the results of
modulating the number of projections on image reconstruction quality in OPT, followed by
concluding remarks in Section 4.1.
Animal ethics statement
Animal procedures were carried out according to Swiss regulations (animal protection ordi-
nance 455.1) under the approval of the veterinary authority of the canton of Vaud (license:
VD3058) and all efforts were made to minimize suffering, following the principle of the
3Rs [121].
Sample preparation with a different embedding procedure
Standard protocols for OPT imaging are usually composed of three parts: organ extraction,
specimen embedding, and optical clearing [85, 86]. Each of these is briefly reviewed in
the following paragraphs, and a different specimen embedding procedure is presented in
Subsection 4.1.
Organ extraction
Organ extraction methods differ depending on the experiment’s design but can include deep
anesthesia and perfusion of the animal to be sacrificed, as well as organ harvesting. Staining is
an optional step that can be performed at different points of organ extraction. For example,
amyloid plaques in a mouse brain with Alzheimer’s disease are stained before sacrifice [55],
whereas antibody staining is performed after the organ has been harvested [104]. In this work,
we used 4 B6SJL F1 mice, one of 8, two of 23, and the last of 51 weeks of age, which were
primarily sacrificed for other experiments but were re-used in our experiments. The mice were
deeply anesthetized with pentobarbital and perfused with 2 ml of heparinized PBS, and 10 ml
of 10 % formalin (HT501128, Sigma). In the 51-week-old mouse, the vasculature was stained
by perfusing the animal with 10 ml of a hydrogel containing FITC-conjugated albumin [92].
After perfusion, we harvested the brain from the 8-, and 23-week-old mice (3 mouse brains).
We also harvested the lungs and a kidney from the 51-week-old mouse (2 mouse organs). All
organs were postfixed in 40 ml of formalin overnight.
Specimen embedding
OPT imaging often requires the sample to be glued on a motorized rotation stage [85]. Direct
contact of the sample with glue impairs imaging and is avoided by embedding the specimen in
agarose gel. Embedding starts by filling a container, such as a Petri dish, with warm 1.5 % (wt/v)
agarose gel. Then, the specimen is transferred to the container’s center and is maintained
in this position until the gel solidifies. Finally and critically, a block containing the sample
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is carved from the gel according to the following principles. Firstly, the amount of agarose
around the sample is minimized to reduce its effect on light penetration. Secondly, the block is
“shaved” to remove acute angles, which could cause light scattering. Lastly, approximately 1 cm
of agarose is left on the side of the sample which will be glued to the rotation stage. Trimming
an agarose block can be a problematic operation as it is brittle. The block’s translucence
results in refraction effects that make it difficult to precisely cut around the sample. Moreover,
edge quality depends on several factors, including block temperature, and blade quality and
handling. Ultimately, trimming is a contributor to variability in the resulting images.
We propose an embedding protocol that significantly reduces related artefacts and associated
variability. Conical-tube-based molds are used to produce agarose cylinders, virtually free
from light-scattering edges (see Figure 4.1). The required materials include: microtome blades,
a pair of inoculation loops, ice in a container and a 15 ml conical tube (Figure 4.1a). The
conical tube is cut with a saw along the 10 ml graduation line, and the conical tip is discarded.
Deburring and rinsing the mold with acetone helps to prevent bubbles when pouring the
agarose inside. The mold is placed on ice and filled with approximately 4 ml of warm 1.5 %
(wt/v) agarose in Milli-Q water (0.22 µm-filtered). The specimen can then be sunk in the
agarose gel and maintained at the mold’s center with inoculation loops (Figure 4.1b). When
the agarose begins to solidify, the inoculation loops are removed. Since only 5-10 ml of
agarose gel are used, the solidification occurs within minutes and is faster than in a whole
Petri. The mold is allowed to cool until complete gel solidification at 4◦ C (Figure 4.1c), and is
subsequently immersed into hot water (approximately 90◦ C) for 10-30 seconds (Figure 4.1d)
to facilitate unmolding (Figure 4.1e). Finally, the cylinder can be trimmed at its extremities,
while remembering to keep at least 1 cm of agarose on one side of the sample. The critical
step of this protocol is to maintain the sample at the center of the mold before agarose gel
solidification. Different mold sizes can be obtained with other conical tube volumes, but 15 ml
tubes were found to be the most suitable for mouse brains, kidneys, and lungs.
OPT images acquired with the custom embedding protocol (Figure 4.2a) are comparable to the
ones from standard embedding protocols (Figure 4.2b and c). In Figure 4.2c, the agarose block
interface is emphasized in the image (red arrowheads) due to poor cut quality performed by
an inexperienced user. However, even if trimming is performed cautiously by an experienced
user, it does not prevent the occurrence of cutting artefacts (red arrowheads in Figure 4.2b).
These images also reveal the presence of a cavity (blue arrowheads) in the agarose block, which
corresponds to the original specimen morphology. After optical clearing with BABB (described
below), specimens were found to have shrunk, as already documented previously [109]. The
custom embedding protocol preserves image quality while the risk of damaging the sample
and introducing cutting artefacts is reduced.
Optical clearing
Optical clearing is an essential part of OPT sample preparation for opaque specimens, such
as mouse organs. Its purpose is to enhance light penetration by making these specimen
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(a) (b) (c) (d) (e) (f)
Figure 4.1 – Agarose mounting in custom molds made from 15 ml conical tubes. (a) Start with
ice in a container, a sharp blade, two inoculation loops, and the part with the cap of a 15 ml
conical tube which was cut along the 10 ml graduation line. (b) Pour warm 1.5 % agarose
solution in the mold on the ice, add the specimen, and, with the inoculation loops, maintain
it at the center of the mold until it starts solidifying. (c) Once the specimen stops moving,
remove the loops quickly and wait for complete solidification. (d) Sink the mold into hot water
for 10-30 seconds. (e) Unmold by gently opening the cap. (f) If necessary, trim the uneven
circular surfaces of the cylinder, while always keeping at least 1 cm of agarose on the end of
the cylinder to be mounted on the instrument.
(a) (b) (c)
Figure 4.2 – Comparison between the different embedding protocols on OPT images of mouse
brain hemispheres. Each image is a maximum intensity projection through 100 slices, which
corresponds to 1.3 mm of tissue thickness. (a) Trimming-free procedure with agarose molding
in conical tubes. (b) Standard trimming procedure performed by an experienced user. (c)
Standard trimming procedure performed by an inexperienced user. The images are saturated
to better visualize mounting artefacts. Blue arrowheads: agarose cavity due to specimen
shrinkage after optical clearing. Red arrowheads: artefacts from agarose trimming. Scale bar:
2 mm.
transparent. In this work, we use the clearing protocol from our previous work [55]. Briefly,
samples are dehydrated in methanol for a day and incubated for two days in a 1:2 solution of
benzyl alcohol and benzyl benzoate (BABB) before imaging.
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Microparticles imaging for OPT characterization
The characterization of an imaging instrument is important to understanding its inherent
limitations and minimizing their effects through methods adaptation. Among the properties
of an imaging system, the point spread function (PSF) is probably the most relevant [122].
The PSF describes the response of the instrument to an ideal point source. In practice, ideal
point sources are taken as known objects which are much smaller than the actual PSF of the
system. For fluorescence microscopy, including OPT, fluorescent microparticles are the tool of
choice [123]. The size of the particles can be determined by estimating the resolution of the
system, which is a measure of the PSF size. We carried out this approach using a custom OPT
instrument [55] built for large-scale specimen imaging. The field of view is 26.6 × 26.6 mm2
with a diffraction-limited resolution of approximately 28 µm. The resolution was improved by
using a camera chip without binning (2048 × 2048 px2), at the expense of image processing
time and storage expenditure. The other instrument’s features are a numerical aperture of
0.01, a magnification of 0.5X, and a working distance of 300 mm. For this characterization,
we opted for 5 µm fluorescent FITC-labeled microparticles (75908-5ML-F, Sigma). These
particles are more than five times smaller than the system’s resolution, which satisfies the
sampling theorem [124], and are sufficiently bright to be imaged by the OPT instrument. The
preparation of the microparticles for OPT imaging uses the molding procedure described in
Section 4.1, where the beads are the specimen. Approximately 0.01 µl of particles are mixed to
10 ml of agarose solution before molding. The acquisition is performed without clearing steps,
which would otherwise bleach the fluorescent signal from these microparticles. The difference
in refractive index between BABB and water in the agarose gel causes light scattering and
aberrations (although negligible with a numerical aperture of 0.01) at the interface of the
agarose cylinder. In this particular case, image acquisition and reconstruction can still be
performed normally. Additionally, BABB and water do not mix. Over time, this makes the
agarose block opaque. Consequently, the microparticle samples are used once and discarded
after imaging.
The results of imaging samples with fluorescent microparticles using our OPT instrument
are presented in Figure 4.3. A total of 99 slices are reconstructed, and a depth color-coded
maximum intensity projection image is generated (Figure 4.3a-c). The instrument shows a
space-varying PSF with a circular shape close to the center of rotation, symbolized with a red
cross (Figure 4.3b). When moving away from the center of rotation, the PSF takes the shape of
an arrowhead pointing toward the exterior of the sample. Furthermore, the size of the PSF
increases with the distance to the center of rotation. Due to the translucent nature of the
agarose gel without clearing, each microparticle is only visible on approximately half of the
projections. This phenomenon is illustrated in the sinogram (0.9 mm in depth) of Figure 4.3d,
where some microparticle traces (blue arrowheads) do not span the 360◦.
In summary, the PSF size of our OPT instrument increases with the distance from the center
of rotation and transforms from a circular to a growing-arrowhead shape pointing towards
the agarose cylinder surface. The varying shape of the PSF currently hinders the computation
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Figure 4.3 – Fluorescent microparticles imaging with the OPT instrument. (a) Depth color-
coded maximum intensity projection of a section from the agarose cylinder mixed with
microparticles. Red arrowheads indicate ring artefacts, which can be used to identify the
center of rotation (red crosses). Color-coded tiles correspond to zoom-in views in (b) and
(c). (d) Sinogram of the microparticle sample at 0.9 mm depth. Blue arrowheads points to
incomplete single particle traces. Scale bar: 1 mm.
of the system’s resolution and depth of field. Additionally, this PSF differs from what was ob-
served by Van Der Horst et al. [125] and Trull et al. [53, 54]. Both reported a radius-dependent
tangential blurring of their PSF from the center of rotation, although with a different instru-
ment. However, the nature of the changes in the PSF shape of our system has led us to think
that these artefacts are related to something else than optics. Indeed, the large increase in
the PSF size cannot be explained with regards to the large depth of field of the instrument
(15.4 mm). Rather, we believe it is caused by the mechanical rotation of the motorized stage.
There could be an eccentricity in the rotation, and there might also be an inaccuracy to gen-
erate constant angular increments. In the future, we want to characterize the rotation stage
motion, measure its positioning precision, and eventually try to correct for systematic errors
we find to improve reconstruction accuracy. However, in the following organ images acquired
with the OPT instrument, the effect of the PSF degradation is difficult to judge and the image
quality is already sufficient to see details of the vascular network.
Assessment of image quality with projection number
OPT imaging requires projections acquired at different angles, over a complete turn, and with
a depth of field covering at least half of the sample thickness to be used by the filtered back-
projection (FBP) algorithm [73] and compute a 3D reconstruction of the sample. In practice,
the number of acquired projections is a parameter chosen by the experimentalist, bearing in
mind that it is directly related to the image reconstruction quality. Indeed, decades of research
in X-ray computed tomography, where FBP was initially applied, have shown that reconstruc-
tions using an insufficient number of projections contain image artefacts [120]. Although a
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greater number of projections imply a higher reconstruction fidelity, several factors limit the
number of angles that can be considered in OPT. More projections imply a prolonged exposure
to the excitation light, which eventually leads to photobleaching of the fluorescence signal. It
also means greater computational memory consumption and longer image processing times,
which is a growing issue for experiments involving numerous specimens. Additionally, the
precision of the motorized rotation stage imposes a minimal angular displacement, although
new motors have a resolution far below 0.1◦ thus enabling acquisitions with more than 3600
projections. Currently, most OPT acquisition protocols rely on 400 projections that are pro-
cessed by the reconstruction algorithm, as was suggested in the original OPT paper [9]. We
believe that the appropriateness of this number depends on the sample type to be imaged
and should be evaluated on a case-by-case basis, as discussed hereafter.
We propose a correlation-based approach to assess how image quality improves with the
number of projection and suggest a method for estimating the appropriate trade-off. Our
method requires a specific acquisition protocol, described as follows. Firstly, a large number of
projections is acquired for the sample of interest, and the resulting high-quality reconstruction
is defined as ground truth. In the present case, 3000 projections were used. Secondly, a series
of reconstructions with a different total of projections (ranging from 100 to 3000 by steps of
100 projections in this case) is computed. The smaller stacks of projections are obtained by
linear interpolation of the ground truth stack. Thirdly, each reconstruction is correlated with
the ground truth and the Pearson correlation coefficient ρX ,Y (PCC), defined as
ρX ,Y = cov(X,Y)
σXσY
, (4.1)
where X is the reconstruction from fewer projections, Y is the ground truth, cov is the co-
variance, and σX and σY are the corresponding variances, is computed. Finally, a plot of
the PCC against the number of projections can be generated. This acquisition protocol was
tested on three samples: a mouse brain, lung, and kidney. The subsequent 3D reconstructions
of these samples are shown in Figure 4.4. Additionally, the protocol was also tested on the
microparticles sample presented in Section 4.1. To reduce the processing time, only a selected
subvolume of the sample underwent the correlation procedure. For mouse organs, 49 slices
were processed, and for microparticles, 99 slices were processed. Ground truth acquisition
times were approximately 9, 12.5, 7.5, and 25 minutes for the brain, lung, kidney, and mi-
croparticles, respectively. During all acquisitions, signal decay due to photobleaching did not
exceed 10 %.
The PCC curves of each sample (mouse brain, lung, kidney, and microparticles) are shown in
Figure 4.5. All curves present a similar behavior. They are almost monotonically increasing
and asymptotically approach 1. However, their growth pattern is specific to the sample utilized.
For example, the mouse brain curve systemically has higher values than the other curves for a
given number of projections. Before we can hypothesize on the reasons behind this behavior,
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(a) (b) (c)
Figure 4.4 – Maximum intensity projections through ground truth reconstruction (from 3000
projections) acquired with the OPT instrument. The specimens are: (a) a 8-week-old mouse
brain morphology, and the vasculature from (b) a 51-week-old mouse lung and (c) a 51-week-
old mouse kidney. Blue arrows indicate the subvolumes used for correlations. Scale bar:
2 mm.
we should notice that all nervous tissues have similar levels of autofluorescence and they
create a rather homogeneous distribution of intensities across the organ (see Figure 4.6). The
resulting image is therefore mainly composed of low spatial frequencies, which are better
captured than high spatial frequencies with fewer projections. The vasculature curves (lungs
and kidney samples) confirm this hypothesis. The vascular network is made of intricate blood
vessels, which result in high spatial frequency image features in the 3D reconstruction (see
Figure 4.6). Therefore, the lungs and kidney require more projections to reach a PCC value
that compares to that of the brain for a given number of projections. Consequently, the small
differences (at least below 1500 projections, as discussed below) observed between the kidney
and lungs curves could indicate a difference in the tissue-specific type of vascularization.
Additionally, the microparticles curve requires an even higher number of projections to reach
a given PCC value (at least below 1500 projections), which is also in favor of the hypothesis
that the curve growth depends on the spatial frequency content of the image. Microparticles
indeed reflect the PSF of the OPT instrument, which is by definition the highest detectable
spatial frequency. Finally, around 1500 projections, the PCC curves of the kidney vasculature,
lungs vasculature, and microparticles intersect. Correlation values above this number of
projections do not have a particular trend. We think this can be attributed to noise in the close
to ground truth reconstruction regime. Therefore it is probably not useful to acquire more than
1500 projections with the current instrument for these types of samples. The autocorrelation
of the ground truth (PCC=1) has been omitted on the plot of Figure 4.5 because it introduced a
jump in the PCC curves at 3000 projections. This jump is another indication that with more
than 1500 projections, differences in the reconstruction are mostly attributed to noise and the
correlation level saturates before reaching 1.
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400 projections (original OPT paper)
Figure 4.5 – Plot of the PCC and corresponding fit against the number of projections for
different samples studied in this work. The curves are monotonically increasing and approach
1 in an asymptotic manner. The amount of projections required to reach a given PCC value
depends on the sample type. Samples with higher spatial frequency content require more
projections, up to a saturation level of approximately 1500 projections. The blue line indicates
400 projections, as suggested in the original OPT paper.








Figure 4.6 – Selected slices from the 3D reconstructions of the mouse brain and right part
of the lungs vasculature. Color-coded tiles indicate zoom-in view reconstructed with an
increasing number of projections (from 100 to 3000).
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As hypothesized, PCC curves could be an indication of the spatial frequency content in an
image. They can assist in deciding the appropriate number of projections to acquire for
OPT imaging of a particular sample. It is worthwhile also looking at reconstructions with a
different number of projections in a single slice of each sample. Such an analysis is shown
in Figure 4.6 for the mouse brain and part of the vasculature of the mouse lung. From these
images, it is clear that reconstructions based on 100 projections are inaccurate and heavily
corrupted by reconstruction artefacts. At 500 projections, streak artefacts remain present in
the lung image, and the brain image has a granular texture. At 1000 projections both images
have considerably fewer artefacts. From 1500 projections onward, image improvements
become marginal, which agrees with our hypothesis that, after 1500 projections, PCC values
reflect more noise fluctuations than improvements on reconstruction quality. Since little
signal decay (<10 %) was observed during the acquisition of ground truth images, we do
not expect this to be a problem at 1500 projections. Additionally, signal decay in that order
of magnitude can be corrected [79]. Regarding acquisition time, the 1500 projections of
mouse specimens presented in this work took 5 minutes, and the memory expenditure for
that amount of projections is approximately 12 Gbytes (2048 × 2048 × 1500 px3 in 16 bits).
The approach described in this section aims at helping OPT users choosing the number of
projections considering their samples and instrument. In our case, we found that mouse
brain anatomy, as well as lungs and kidney vasculature, are accurately reconstructed with
1500 projections without prohibitively compromising the acquisition duration or memory
consumption. Moreover, the computation of a PCC curve from microparticle images can
provide information on the number of projections at the limit of the instrument resolution,
which can serve as an upper bound to the number of projections. Since microparticle images
are likely to be acquired infrequently in OPT instruments, we suggest to select a large number
of projections for their reconstructions as the improvement in image quality is not fully
understood yet. In our case, we would still acquire 3000 projections for our microparticles
samples.
Finally, we fitted the PCC curves with an exponential function
ρX ,Y (n)= a−b exp−cn , (4.2)
where n is the number of projections and a, b, and c are the fit coefficients. These fits are
plotted in Figure 4.5 and the coefficients are summarized in Table 4.1 with the resulting R-
square value. They can be used to infer on the PCC value for any given number of projections.
Conclusion
In this paper, we discussed several aspects of OPT imaging: sample preparation, with a focus
on specimen embedding, instrument characterization with fluorescent microparticles and
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Table 4.1 – Fit coefficient and R-square value for the four different PCC curves in Figure 4.5.
Sample a b c R-square
Brain 0.9892 0.3303 0.004256 0.9823
Lungs 0.9649 0.6108 0.003656 0.9918
Kidney 0.9727 0.576 0.00286 0.9922
Micro particles 0.975 0.7023 0.002736 0.9958
the influence of the number of projections on the subsequent reconstruction with the FBP
algorithm. Each aspect provides a starting point to be further investigated. Microparticle
imaging can serve to understand the instrument behavior and specifications, such as the point
spread function and resolution. A better knowledge of these features can help in designing
deconvolution methods for OPT as suggested by Van Der Horst et al. [125]. However, as
microparticle imaging depends on the instrument properties, such as numerical aperture,
motorized rotation stage precision, and detector, it needs to be systematically conducted
on different setups. Similarly, the analysis of the number of projections could be used to
find an adaptive criterion for the automatic determination of this parameter, given a sample.
Ultimately, in discussing these aspects, we aim to help standardize the OPT technology and
make it more accessible to life scientists.
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5 OPT applied to Alzheimer’s disease
In the last two chapters (Chapter 3 and 4), we have demonstrated the performance of OPT in
the context of mouse whole-organ imaging, with an emphasis on the brain. An essential part
of neurodegenerative diseases research is done on mouse brains, and its role in elucidating
the etiology of diseases such as Alzheimer’s disease (AD) is critical. In the OPT images of
amyloid plaques in whole mouse brains, we have seen a mixed contrast between the tissue
autofluorescence and the plaque-specific signal. This mixed contrast makes it difficult to
separate the plaques from their surroundings. A means of isolating amyloid plaques for
quantification would be extremely valuable to observe the disease progression and assess
treatments efficacy. In this chapter, we demonstrate for the first time segmentation and
quantification of amyloid plaques in whole mouse brains of AD mice with a supervised
learning algorithm based on random forests [126]. The performance of the method was
evaluated in a preliminary cross-sectional study, and the results are presented in a research
article submitted to Biomedical Optics Express in December 2018. This section is composed
of the preprint version of the article, followed by a detailed list of author contributions.
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Alzheimer’s disease (AD) is characterized by amyloidosis of brain tissues. This phenomenon is
studied with genetically-modified mouse models. We propose a method to quantify amyloido-
sis in whole 5xFAD mouse brains, a model of AD. We use optical projection tomography (OPT)
and a random forest voxel classifier to segment and measure amyloid plaques. We validate our
method in a preliminary cross-sectional study, where we measure 6136±1637, 8477±3438,
and 17267±4241 plaques (AVG ± SD) at 11, 17, and 31 weeks. Overall, this method can be
used in the evaluation of new treatments against AD.
Introduction
Amyloidosis in brain tissues is associated with several neurodegenerative diseases, including
Parkinson’s and Alzheimer’s disease (AD). In AD, toxic extracellular aggregates of a truncated
and thus misfolded amyloid precursor protein form deposits known as amyloid plaques [127,
128]. These plaques have a spherical shape, and their size varies between approximately ten
and one hundred micrometers. The neuropathological nature of the plaques is hypothesized
to play a central role in the etiology of AD and is at the core of Alzheimer’s disease research [66].
The mechanisms of plaque formation and their consequences remain elusive and are com-
monly studied in genetically modified rodent models, such as the 5xFAD mouse model [105].
Such models are designed to reproduce the age-dependent amyloid deposition observed in
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humans [129].
The standard technique used to visualize and quantify amyloid plaques is histopathology
wherein sections of brain tissue are sliced, mounted on glass cover slides, stained, and imaged
with either a widefield or a fluorescence microscope. Histopathology is an invaluable diagnos-
tic tool but has some limitations. Strict sample preparation protocols and a well-practiced and
meticulous expertise are required. In addition, reproducibility across samples is challenging
to obtain, and artefacts related to sample preparation are nearly unavoidable. Furthermore,
three-dimensional renderings of whole brains remain prohibitively time-consuming. As a
consequence, this technique only allows observing the development of amyloid plaques in
local, arbitrarily chosen areas of the brain, making an objective comparison between speci-
men difficult. Other less invasive techniques exist to image amyloid plaque growth in vivo,
such as two-photon microscopy [130], optical coherence microscopy [68], and photoacoustic
microscopy [131]. All three techniques can resolve individual plaques consistently while
preserving brain integrity through the use of cranial windows. They can cover several square
millimeters of tissue over hundreds of micrometers in depth, but fail at imaging over the
whole brain. Differential phase contrast tomography [132] and contrast-enhanced magnetic
resonance microscopy [133] can produce images of amyloidosis in whole intact rodent brains
with a resolution of a few tens of micrometers. However, they require expensive instruments
with specific sample preparation protocols and are therefore not routinely used. Ultrami-
croscopy [134] is another technique for visualizing amyloidosis in whole-excised mouse
brains [43, 135]. It is a mesoscopic adaptation of light sheet microscopy, where a sheet of light
illuminates the sample orthogonal to the detection path, thus producing optically sectioned
fluorescence images of the organ with minimal photobleaching. Similarly, optical projection
tomography (OPT) [9] can perform whole mouse brain neuroanatomical phenotyping [50] and
amyloidosis imaging [55] by acquiring fluorescence projections of the organ at different angles
over a complete turn. Although ultramicroscopy and OPT are complementary techniques,
ultramicroscopy often offers a better resolution, while OPT is generally easier to implement
and more robust to misalignment.
To quantify amyloidosis progression from image data, the standard protocol is to process
specimen with an amyloid plaques-specific staining such that the plaques stand out from
other tissue elements. A segmentation mask is then obtained by identifying which image
elements correspond to amyloid plaques. From there, the number of plaques and volume they
occupy can be estimated. When imaging the whole brain at once, a significant challenge is
the staining of the intact organ. For amyloid plaques, Methoxy-X04 [136] is one of the only
probes that can be used due to its ability to penetrate the blood-brain barrier. However, the
excitation of Methoxy-X04 (in the near-UV/blue) also generates a strong signal from tissue
autofluorescence. Therefore, quantitative image-based analysis of amyloidosis relying on
voxel intensity thresholding, as typically used in histopathology data, cannot be performed.
Amyloid plaques are indeed indistinguishable from tissue autofluorescence based on intensity,
henceforth requiring a more complex image analysis approach. In the work of Jährling et
al. [43], plaques could be isolated in ultramicroscopy images by applying intensity thresholding
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since small sub-volumes called cubes were considered instead of the whole brain volume.
Quantitative analysis was then run through six of these cubes per sample. Statistical analyses
are performed on the sub-volumes but they do not reflect the brain-wide plaque distribution.
In this paper, we propose a supervised learning pipeline relying on random forest voxel
classifiers to segment and quantify amyloid plaques in whole 5xFAD mouse brains of different
ages acquired with OPT.
Learning-based automated classification for AD has gained a strong interest in recent years.
The disease is indeed currently diagnosed based on clinical examination, and classification
of AD samples, preferably at an early stage of the pathology, holds a strong potential for
adding validity to the diagnosis. Signal-based classification already allowed identifying mark-
ers to aid in Alzheimer’s disease diagnostic from diffusion tensor imaging scans [137], EEG
signals [138], intracellular recordings [139], or multiple sources including various 3D imaging
modalities [140].
Regarding tissue imaging data, BioVision [141] was proposed as a supervised training approach
for image-based identification of histopathological objects. This approach, relying on a pixel-
based Bayesian classifier, has been used for the quantification of amyloid plaques in histology
images [142]. A similar approach was followed by Vandenberghe et al. [143] on the same type
of data, showing that random forest classifiers exhibited better performance. The work of
Li et al. [144] also illustrates the good performance of pixel-based decision tree algorithms,
this time for the pixel-based classification of MRI image data. An essential aspect of these
previous works is that the classification algorithm operates on pixels in 2D slices. Another
way to approach the problem of identifying brain components from images is atlas-based
segmentation [145, 143]. In this setting, a labeled model (the atlas) of the 3D organ is deformed
to fit the 3D image volume at once. From the resulting boundaries of each labeled regions,
statistics can be derived at the local level.
As no atlas labels are available for mouse brain in OPT data, the approach we propose considers
3D voxels in image volumes without an underlying atlas. It is, to the best of our knowledge, the
first attempt to introduce a learning-based method for amyloid plaques detection in OPT im-
age data and, more generally, to quantify amyloid plaques relying on a pipeline incorporating
information from all three dimensions in an atlas-free setting.
Our manuscript is structured as follows. Firstly, we briefly describe the sample preparation
and imaging setup, which we introduced in our previous work [55]. Secondly, we present the
supervised learning pipeline for segmentation and quantification of amyloidosis. Supervised
learning provides an efficient way to learn, from a set of manually annotated examples, how
image features such as e.g., grayscale intensity and textures [146], should be combined to
segment objects of interest in images [147]. In particular, pixel- and voxel-based random forest
classifiers have proved their efficiency for bioimage segmentation tasks [148, 149]. We choose
to rely on that specific type of algorithms for two main reasons: first, random forests are well-
suited for classification tasks with few training data; and second, they can be used through
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the ilastik [150] interface. ilastik is an open-source image analysis software, which provides
a user-friendly GUI for training and reusing trained classification workflows for prediction.
In that way, we aim at making our image analysis pipeline easily reusable with or without
additional training. Thirdly, we showcase the results of the segmentation and quantification
in 5xFAD mouse brains of different ages. Finally, we discuss the impact and limitations of our
study and give some recommendations based on our preliminary results.
Materials and methods
Sample preparation
Experiment animals, 5xFAD mice [105] on a B6SJL F1 background, were generated by crossing
5xFAD transgenic females on a C57BL/6J background (34848-JAX, MMRRC) with wild type
SJL/J males (000686, The Jackson Laboratory) in the local animal facility (housing conditions
are described below). The disease phenotype is observed to be more robust on this hybrid
background [151]. The 5xFAD mouse model is commercially-available and widely-used in
AD research. The mice develop a severe amyloid pathology starting around 1.5 months with
high levels of accumulation in the subiculum [105]. Animal procedures were carried out
according to Swiss regulations [152] (animal protection ordinance 455.1) under the approval of
the veterinary authority of the canton of Vaud (license: VD3058), and all efforts were made to
minimize suffering, following the principle of the 3Rs [121]. Experiment animals were housed
in ventilated cages (maximum 5 animals per cage) under a 12h light/dark cycle (lights on at 7
a.m.) and controlled atmosphere (23 ◦C and 50% relative humidity) with ad libitum access
to food and water. Two 5xFAD transgenic females on a C57BL/6J background were housed
with one wild type SJL/J male in the breeding cages under the same conditions as experiment
animals, but the extreme aggression of SJL/J males [153] hampered the breeding capacity.
Indeed, 5 out of 12 females in the 6 breeding cages (that we shared with other experimentalists)
were found dead with lethal lesions from fights with the males. To refine our breeding protocol,
we decided to move the males in individual cages when the females were pregnant. However,
this measure was not sufficient to prevent casualties in the breeding cages, and it reduced
the number of experiment animals that could be generated, more details can be found in the
discussion section.
Brains were processed as described previously [55]. In summary, the mice were injected with
Methoxy-X04 (Tocris) [136], a fluorescent marker that targets amyloid plaques. Then, they
were deeply anesthetized using an overdose of pentobarbital and perfused with a 10% formalin
solution. The brains were extracted and post-fixed in formalin overnight. Each organ was
mounted in a 1.5% agarose gel and cleared using BABB before imaging. An illustration of these
steps is shown in Fig. 5.1A.
Ten experiment animals could be retrieved from the breedings and were divided into three
age-groups after amyloidosis onset (Tg/0): a young one at 11 weeks old (n = 3), a middle-aged
one at 17 weeks old (n = 4), and an old one at 31 weeks old (n = 3). A fourth control group
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Figure 5.1 – Sample preparation and experimental setup. (A) Photographs of a mouse brain
through the different steps of the preparation protocol. (B) Scheme of the optical projection
tomography setup. AL, aspheric lens; RL, relay lens; EX, excitation filter; DC, dichroic mirror;
M1/2, mirrors; OL, objective lens; EM, emission filter; DI, diaphragm; TL, tube lens; ro,
rotation.
(n = 2) was formed with B6SJL F1 mice (+/+) that did not have the transgenes. The control
group followed the same sample preparation as the experiment groups, including Methoxy-
X04 injection. All samples and their corresponding group are recapitulated in Table 5.1. As
indicated in the third column, some samples are composed of only one hemisphere of the
brain, as some specimen had to be shared with other experimentalists.
Optical projection tomography
Whole brain imaging was performed with a custom OPT setup [55] shown in Fig. 5.1B. The
instrument is similar to an epifluorescence microscope. It uses a 420-nm LED light source and
a 300-mm achromat objective lens (OL) to produce fluorescence projections of the sample
with a 0.5X magnification. The fluorescent light is filtered using a custom filter set from
Chroma composed of a dichroic (DC) mirror (AT455dc), an excitation (EX) filter (AT420/40x),
and an emission (EM) filter (AT465lp). A diaphragm (DI) in the rear focal plane of the OL
enlarges the depth of field to guarantee a sharp focus through the front half of the sample.
Projections are acquired over 360 degrees by steps of 0.3 or 0.9 degrees in approximately
five minutes. The three-dimensional reconstruction of the sample is achieved by applying a
filtered back-projection [73] to these projections. To do so, we perform the same procedure
as described previously in [55], and refer the reader to the latter work for more details. In
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Table 5.1 – List of samples processed. The ∗ indicates samples, which were partially annotated
for the training of the random forest classifiers. The † indicates samples, which were used to
generate Fig. 5.4. Tg/0, transgenic animals; +/+, wild type animals.
Id Age [weeks] Structure Genotype Image size [px3] Group
0† 11 Whole Tg/0 407x344x514
Young1∗ 11 Hemisphere Tg/0 283x288x517
2 11 Hemisphere Tg/0 268x321x569
3 17 Whole Tg/0 300x274x590
Middle-aged
4 17 Whole Tg/0 317x243x650
5† 17 Hemisphere Tg/0 446x307x602
6 17 Hemisphere Tg/0 442x320x577
7∗,† 31 Whole Tg/0 420x357x603
Old8 31 Whole Tg/0 411x389x597
9 31 Whole Tg/0 427x384x615
10 7 Whole +/+ 352x340x512
Control
11† 31 Whole +/+ 432x334x576
this configuration, the OPT setup has an isotropic resolution of approximately 50 µm over
the whole organ. The current resolution does not allow to measure small plaques (10-50 µm).
However, the intense brightness of the plaques still makes them detectable for counting.
Image segmentation and quantification
The overall image-based segmentation and quantification process from reconstructed pro-
jections is depicted in Figure 5.2. Once 3D image volumes are reconstructed with a filtered
back-projection algorithm, images are normalized using Fiji [107] and its contrast enhance-
ment tool before segmentation to accommodate for differences in dynamic range stemming
from variations in, e.g., image acquisition time. During normalization, 0.1% of the total
amount of voxels (stack histogram) is allowed to be saturated in the image to account for
outliers. This normalization step is crucial for the quality of the subsequent segmentation
of amyloid plaques. As voxel intensity is part of the feature set considered by our proposed
supervised learning approach, all image volumes must be brought to a comparable dynamic
range, both in the training and prediction phases.
We segment plaques from background and brain image elements using a supervised learning
approach. To do so, we designed a 3D voxel classification workflow in the open-source image
analysis software ilastik [150]. The image analysis pipeline consists of two steps. First, training
is performed from manual annotations of a few voxels in a small selection of image data. Then,
the trained supervised learning algorithm predicts the type of the remaining unannotated
voxels in these image data, as well as the type of each voxel for the ones left aside during
training. In our case, random forests [126] are used as learning algorithm. The working
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Figure 5.2 – Processing pipeline. From OPT acquisition, the projections are used to recon-
struct a 3D image with a filtered back-projection algorithm. After a normalization step, a
random forest classifier identifies voxels corresponding to plaques in the image volume. Quan-
titative measurements can be extracted from the segmentation mask, and statistical analyses
can be conducted.
principle of this approach is as follows. A set of numerical measurements, called features, is
computed for each object to be classified (in our case, the voxels). These measurements aim
at describing the object in terms of, e.g., color, shape, neighborhood and serve to distinguish
objects belonging to different classes (in our case, plaques versus everything else). The specific
nature of the features we rely on is described hereafter.
In the training phase, given (a) a collection of objects, (b) their feature values, and (c) their
known class labels, several decision trees are built by randomly picking features and searching
for proper decision boundaries to separate between classes. Starting from the root, each
intermediate node in a decision tree corresponds to a specific feature, while leaves correspond
to class labels. In the prediction phase, given an object and its collection of computed features,
each tree is explored to predict the class as follows: the value of the feature corresponding
to the root node is examined, and dictates which branch to follow. This process is repeated
at each intermediate node until a leaf is reached, which predicts the class of the object. The
final class probability estimates are obtained as the percentage of trees predicting the object
to belong to each considered class. The overall classification procedure with random forests is
illustrated in Fig. 5.3.
The choice of a specific supervised learning algorithm among the vast variety of those available
is generally dictated by the constraints that are inherent to the considered problem. In our case,
following the principles of the 3Rs, we want our approach to be able to train based on a small
number of samples. Moreover, we aim at maximizing the reusability of our pipeline, which
implies limiting handcrafted steps and relying on well-established processing environments.
These considerations guided our choice for random forests to segment plaques. Random
forests indeed provide an excellent trade-off between generalization capability and ability
to learn from few training examples [154]. This last point specifically makes them preferred
over the currently popular convolutional neural networks, which require training datasets of
significantly larger size than the ones considered in this work. In addition, random forests
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are available through the ilastik GUI, which maximizes user-friendliness during the training
phase and ease of use when predicting on new data.
In the training phase, manual annotations were provided for each of the three classes, here
corresponding to background, brain, and plaques. Our underlying assumption motivating this
setting is that, although plaque signal cannot easily be separated from the autofluorescence
signal from brain tissues using a simple intensity-based threshold, it does stand out when
considering a combination of texture, intensity and shape measurements. The random
forest classifier, therefore, acts as an adaptive way to learn a complex threshold combining
these different features to isolate plaques from the rest of the image volume content. The
specific voxel features we rely on were computed through the 3D volumes. They can be
grouped in three categories: color-based (i.e., voxel intensity values), edge-based (i.e., various
edge detectors such as gradient filter, difference of Gaussians, and Laplacian of Gaussians),
and texture-based (e.g., eigenvalues of structure tensor, Hessian matrix). All features were
computed at various image scales; that is, on the original image volume as well as on the
image volume processed by various levels of Gaussian smoothing.
When relying on learning-based approaches, the selection of training elements, which are
used as ground truth, is of major importance as it influences the generalization capability
and overall performance or the algorithm. We selected samples 1 and 7 (see Table 5.1) for
training. These two image volumes, one corresponding to a young and one to an old specimen,
were chosen to avoid age-induced batch effects [155]. A few manually labeled voxels were
distributed through the whole volume along the X, Y and Z planes to minimize training bias
and reduce the risk of overfitting. Once trained, the pipeline was used to predict plaques in
all remaining dataset. To assess the false positive rate of the random forest classifier trained
in this way, we also ran the pipeline on brain image volumes of negative control specimen to
report the amount of erroneously predicted plaques. Results are provided in Table 5.2 and
testify the specificity of the method.
We then reused the same background and brain voxel labels but removed the plaque class to
train a 2-class random forest voxel classifier and retrieve a whole brain segmentation mask.
This second step allows us to compute an estimate of total brain volume, which is used to
extract the ratio of plaque volume to the whole brain.
Due to data size (see Table 5.1 for details), all considered image volumes were first converted
from .tif stacks to .h5, processed with ilastik, and converted back from .h5 to .tif for visualiza-
tion purpose.
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Figure 5.3 – Classification procedure with random forests. For the sake of simplicity, 2D
pixels and a 2-class problem are depicted. (A) Training phase. A few voxels from each classes
(here A, the object, and B, the background) are manually labeled as ground truth. A collection
of measurements, referred to as features, are extracted to characterize these voxels. Here,
only two (intensity and texture-based features) are shown. A forest of decision trees is then
constructed. Each stage of a decision tree is built by randomly picking a feature and choosing
a boundary value that best separates each class according to this measurement. Here, three
trees are shown. (B) Classification, or prediction, phase. For each unlabeled voxel, the same
set of features as in training phase are extracted. These measurements are then fed to the
random forest trees, which provide class prediction. The final probability is retrieved as the
percentage of trees predicting each class.
Results
Imaging of amyloid pathology progression
Selected three-dimensional brain images from the three groups of mice are shown in Fig. 5.4A-
C. As reported previously [55], the emission signal of Methoxy-X04 is deeply mixed with tissue
autofluorescence. Therefore, both the amyloid plaques and brain anatomy can be visualized
in a single OPT acquisition. Amyloid plaques can be identified from the strong fluorescent
signal they emit as well as from their characteristic small spherical shape. As expected, strong
age-dependent amyloidosis is observed in the subiculum, indicated by the white arrows. These
images already give us a qualitative feeling for the progression of the amyloid pathology, which
worsens with age. However, as previously mentioned, thresholding based solely on voxel
intensity as often performed on histopathology data is inefficient for quantitative analysis.
The cerebellum, indicated by the blue arrows, indeed exhibits similar voxel intensity levels as
plaques, possibly caused by different autofluorescence contrast mechanisms. Likewise, the
cortical barrel fields (white arrowheads), which are dense anatomical features of the mouse
brain, reach high levels of autofluorescence intensity. Ultimately, perfusion artefacts, such as
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blood-containing vessels (blue arrowheads), also corrupt the outcome of intensity threshold-
based segmentation due to the strong autofluoresence of hemoglobin. Therefore, correct
isolation of amyloid plaques from the whole brain requires to rely on a combination of several
visual aspects such as their texture, shape, and intensity. A brain image from the control group















Figure 5.4 – Imaging of amyloid pathology progression. (A-C) Renderings of OPT images
from the three age-groups: young, middle-aged, and old, respectively. Blue arrows, cerebellum;
White arrows, amyloid plaques in the subiculum; Blue arrowheads, blood vessels; White
arrowheads, cortical barrel fields. (D) Rendering from the control group. (E-H) Corresponding
renderings after random forest classification and thresholding. The amyloid plaques, in yellow
(thresholded at 0.5), are overlaid with the brain anatomy, in grey (thresholded at 0.7), whose
transparency is reduced for visualization purposes.
Quantification of the amyloid plaques
The outcome of the voxel classification workflow described above provides an efficient way to
segment amyloid plaques based on a mixture of their visual features. For each voxel in an OPT
image volume of a diseased brain, the 3-class random forest classifier returns a probability
value (0-1), yielding a 3D probability map image. The value of each voxel in the probability
map image corresponds to the likelihood that the corresponding voxel in the original image
belongs to an amyloid plaque. A segmentation mask isolating amyloid plaques is thus obtained
by thresholding the 3D probability map at 0.5. This threshold can be directly interpreted as
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retaining only voxels with a higher-than-50-percent chance of belonging to a plaque. We
found it to be sufficiently sensitive for plaque detection against the strong background while
maintaining a certain level of specificity, which is discussed at the end of this section. The
same procedure can be carried out to segment brain anatomy relying on the probability map
output of the 2-class random forest classifier and a threshold of 0.7. The sensitivity to brain
tissues is indeed observed to be higher due to a consistency in the autofluorescence signal,
allowing us to increase the threshold value to gain more specificity. Segmentation results of the
selected brain images from the three age-groups are shown in Fig. 5.4E-H. The transparency
of the brain anatomy channel was reduced to enhance the visibility of amyloid plaques. As
expected, we observe an increase in the number of plaques with age.
Moreover, the classifier seems to have captured the different features that make amyloid
plaques apparent in OPT images. For example, the cerebellum is properly excluded as it
does not appear to show amyloid deposition, which is in agreement with known results [105].
Despite its strong fluorescence intensity, it does not meet the other visual criteria to be
associated with the amyloid plaque class. The same observations hold for the cortical barrel
fields and perfusion artefacts.
After segmentation, we perform a quantitative analysis of the amyloid plaques in the brain
by computing the ratio of plaque volume to the total organ volume. This measure is referred
to as plaque load and is expressed in percentage. Additionally, the total plaque count pro-
vides another quantitative measure of amyloidosis. Regions of dense deposition, such as the
subiculum, exhibits the formation of clusters of amyloid plaques in OPT images due to the
resolution of the instrument and the normalization step. To refine our estimate of plaque
count, we measured the average size of a single plaque and divided the total area of all larger
plaque clusters by this value in each sample. Since small plaques have a size comparable to
the instrument resolution, we might overestimate the plaque load.
Additionally, as mentioned previously and reported in Table 5.1, some samples of our study are
single brain hemispheres. To allow for a fair comparison of the total number of plaques with
full brain samples, we reported twice their measured plaque count. This choice is motivated
by current observations of brain amyloidosis, which suggests a symmetry of the pathology
between brain hemispheres [156]. To further validate this procedure, the 3D image of a whole
31-week-old brain (sample 7 in Table 5.1) was digitally split and the number of plaques was
counted in each hemisphere. A total amount of 8418 and 7467 plaques in the left and right
hemisphere were obtained respectively, which corresponds to a ratio of 0.53 and 0.47 when
divided by the total number of plaques. We thus believe that assuming that the plaque count
in a single hemisphere roughly corresponds to half of the total plaque count in the whole
brain is a reasonable hypothesis. The results of the quantitative analysis of all samples are
summarized in Table 5.2.
Providing results from alternative methods for a reasonable comparison to our approach
appears to be challenging. Existing solutions for the automated image-based assessment
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of amyloid plaques are indeed designed for imaging modalities of entirely different nature
(e.g., histopathology, MRI) and, most importantly, trained at a pixel (and not voxel) level.
Considering the choice of the algorithm, random forests through ilastik pragmatically appears
to be the most efficient solution to maximize user-friendliness in re-training and prediction
mode, while ensuring good performance based on a small training set. We are not aware of a
convolutional neural network or support vector machine implementation that provides these
two features at once.
Unfortunately, no gold standards are available for the labeling of amyloid plaques in 3D OPT
image volumes. Although this prevents a rigorous evaluation of the performance, we relied on
expert opinion to assess the validity of the segmentation results from a qualitative point of
view. They were considered to be accurate from a purely visual perspective.
Since our method has been designed to be easily reusable, all results provided in this paper
can be directly reproduced by importing the image analysis pipeline in ilastik, which holds
all the necessary information regarding algorithmic parameters, and running it on the raw
data (the image analysis pipeline and raw data are available at the Open Science Framework).
Annotations provided for training can as well be visualized and the algorithm re-trained from
user-provided brush strokes on images through ilastik’s GUI.
Table 5.2 – Quantitative measurements of amyloid plaque quantity in all samples. The
∗ indicates samples which were partially annotated for the training of the random forest
classifiers. The † indicates samples, which were used to generate Fig. 5.4. The mean and
standard deviation (SD) is included for each measure and group, which are compared in this
study. The control group serves as quality control.

































Ultimately, we performed a statistical analysis of our results, illustrated with boxplots in
Fig. 5.5. For the plaque load, there is no statistically significant difference between groups as
determined by one-way ANOVA (F (2,7)= 4.733, p = .05). However, we still performed a post-
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Figure 5.5 – Representation of the amyloidosis statistical analysis Boxplots of the quantita-
tive measures of amyloid progression for each group of mice. *, p < .05 (Tuckey’s test); n.s.,
not statistically significant.
hoc Tuckey comparison since p =α= .05, and we found a statistically significant difference
between the young and old group (p < .05) (with a 5% chance of it being a false positive).
Moreover, a statistically significant difference in total plaque number is observed by one-way
ANOVA (F (2,7)= 9.609, p = .01). Tuckey’s test showed that the old group differs significantly
(p < .05) from the middle-aged and the young group.
As a quality control, we performed the quantitative analysis on negative controls (Table 5.1).
Both the plaque load and plaque count show a reasonably low amount of false positives
(Table 5.2), demonstrating the specificity of our analysis.
Discussion
The segmentation of amyloid plaques from whole images of 5xFAD mice brains acquired with
OPT shows promising results, as seen in Fig. 5.4E-H. However, limited statistically significant
differences are drawn from the group analysis. We believe that this restricted statistical
significance, observed in spite of the visually encouraging segmentation outcome obtained
with our method, can be attributed to three different factors: the plaque load, number of
plaques and number of samples. We now describe in more details how these three aspects
affected results in our experimental setting, and propose solutions to minimize their adverse
effect in further experimental designs.
Firstly, plaque load is a standard measure of amyloidosis in sections with high plaque density
from histopathology data. In our experimental design, sample calculation is based on the
findings of Bolmont et al. [68], who observed a difference of approximately 1.6 percent in the
plaque load between 2 and 4 months of age, using a different mouse model. However, when
calculated for the whole brain of 5xFAD mice, plaque load hardly reached 0.5 percent, with
differences of 0.1−0.2 percent between groups. Therefore, our design is not appropriate to
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observe such small differences: there is not enough plaque load difference between the age
groups we consider when observing the whole brain at once, as opposed to studying a small,
specific local section of it. Moreover, comparison of sections in OPT images is hard to achieve
due to the difficulty of reliably finding matching sections in the image volumes. Larger groups
should thus be considered to observe a statistically significant difference in amyloid plaque
load.
Secondly, only limited information about the total number of plaques can be found in the
literature. Jährling et al. [43] observe a difference of several thousands of plaques between
young (10 weeks old) and old (28-34 weeks old) animals. Although these measurements
come from a different mouse model of amyloidosis and the total plaque count does not
represent a whole brain, they were the most sensible known results for our work and thus
served as a basis for our experimental design. Our results suggest that their plaque number
estimate was a reasonable starting hypothesis, but that the variability in total plaque count
was underestimated. The inter-specimen plaque number variance observed in small cubes
is indeed drastically lower than in the entire brain volume. The young (11 weeks old) and
middle-aged (17 weeks old) groups seem to be too close in terms of age to be able to observe a
statistically significant difference. Our quantification method might not be sensitive enough to
capture changes in amyloidosis under 6 weeks of age difference, as there is not enough disease
progression in this period to detect a statistically significant difference in levels of amyloidosis.
For that reason, we recommend having at least 8 weeks (2 months) of age difference between
groups.
Thirdly, when using 5xFAD mice on a B6SJL F1 background, the extreme aggressivity of
the SJL/J males in the breeding cages must be considered in the experimental design as
casualties are more likely to happen, thus reducing the number of generated specimens.
Having witnessed this, we suggest using the congenic 5xFAD strain, on a C57BL/6J background
instead. Animals should then be generated by back-crossing females 5xFAD (34848-JAX,
MMRRC) with C57BL/6J males (000664, The Jackson Laboratory). We nevertheless believe
that the results of our quantitative analysis can be used as a preliminary study. Based on our
findings, in order to observe a statistically significant difference of 0.15 percent with a standard
deviation of 0.15 percent in the plaque load relying on a one-tailed t-test, 16 animals are
required in each age-group (α= .05 and power= .85). Concerning the experiment duration, in
our experience, 8-12 animals can be sacrificed per day, and the remaining sample preparation
takes 4 days (count 1 day to embed the samples in agarose and 10−20 minutes per following
day to change clearing solutions) plus 1 day of imaging.
In summary, it is noteworthy to take into consideration that quantifying the plaque load in
whole mouse brains is inherently subject to more variability compared to other techniques,
which focus on smaller regions of interest. Therefore, a more substantial amount of samples
is necessary and care must be taken in the experimental design to take into account the
variability factors mentioned above. However, our technique, which considers the organ in its
entirety, offers a wealth of information for AD research. When looking at individual images,
65
Chapter 5. OPT applied to Alzheimer’s disease
our approach allows to isolate amyloid plaques from the rest of the brain adequately. The
plaque patterns are also observed to be similar to what has been previously observed [105].
Plaque load might be overestimated due to the instrument resolution, causing smaller bright
plaques to appear with a size of approximately 50 µm. To our knowledge, it is the first time that
the plaque load and the total number of plaques are measured in the whole brain of 5xFAD
mice.
Our approach, being atlas-free, does not provide information about the locality of the plaques.
As a trade-off, it results in a computationally lighter segmentation approach. Incorporating la-
bels to perform atlas-based segmentation is a natural future avenue to pursue. Such additional
structure knowledge could, in fact, be combined with our method by including atlas-based
information as features to be considered by the random forests.
Conclusion
In this paper, we propose an image-based analysis pipeline for the quantification of amy-
loidosis. The pipeline is applied to whole brain images of 5xFAD mice, a mouse model of
Alzheimer’s disease. Image volumes are acquired with an optical projection tomography
instrument, and amyloid plaques are segmented relying on a random forest voxel classifier.
The plaque load and the total number of plaques are then consistently measured in the whole
organ. The pipeline has been tested on 3D OPT images of brains of mice at different ages to
illustrate the age-dependent disease progression. This preliminary study shows a statistically
significant increase in the number of plaques in old animals (31 weeks old) compared to young
and middle-aged ones (11 weeks old and 17 weeks old, respectively). Although the other
group differences are not statistically significant, we believe the study should be repeated with
more animals to draw more complete conclusions with regards to the disease progression.
While there isn’t a strict statistically significant difference in the plaque load (p =α), a Tuckey
post-hoc analysis revealed that the old group differs significantly from the young one. Isolation
of plaques from the strong background autofluorescence signal is observed to be successful,
and tests on negative controls show a negligible false positive rate. We provide the image
volumes and manual annotations used for training, as well as the pre-trained ilastik workflows
for download and further use by the community at the Open Science Framework.
In the future, we would like to take advantage of the tissue autofluorescence to segment
regions of interest in the brain, such as the subiculum, which is the region where most of
the deposition occurs in 5xFAD mice and estimate a local plaque load. Additionally, the
pipeline could be reused for data acquired with other mesoscopic imaging modalities, such as
ultramicroscopy, and in different rodent models of amyloidosis. Ultimately, we would like to
use light sheet microscopy to establish a gold standard for amyloid plaques in the whole brain




OPT reconstructed data sets and ilastik pipelines are available at the Open Science Framework
with a README document on how to use them.
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6 OPT towards cell imaging
In optical microscopy, there is a fundamental limitation given by the detector size and its
pixel number. Common scientific CMOS cameras have a square 1.3 × 1.3 cm2 detector with
2048 × 2048 px2 (the physical pixel size is 6.5 × 6.5 µm2). Imaging of a whole mouse organ
can require up to 2 × 2 cm2 in the case of the liver [157]. Therefore, a field of view (FOV) of
2.6 × 2.6 cm2 can be realized with such detectors using a 0.5X magnification, as featured in
the OPT instrument considered in this thesis. However, the image pixel size becomes 13 ×
13 µm2, and the maximum attainable resolution in a single image is given by twice this size
(following Shannon sampling theorem [124]), i.e., 26× 26 µm2. There are then two approaches
to improve the resolution down to micrometer level. Both allow cell imaging but require the
acquisition of more images.
The first approach consists of acquiring a mosaic of smaller images with higher magnification
and stitch them together in a post-processing step. It is often the chosen solution in light sheet
microscopy [158]. However, in standard OPT, this approach provides a limited improvement
on projection resolution due to the depth of field (DOF) requirements, stated as follows.
Whatever the size of the image on the camera, the DOF is at least half the specimen thickness
in standard OPT (Section 2.2). Therefore, images at high magnification will have the same
resolution as lower magnification ones. There has been an attempt to perform OPT in a region
of interest (ROI) of the specimen with remote focal scanning OPT [52] but the acquisition
protocol only works in ring-like areas centered on the axis of rotation.
The other approach combines imaging modalities. For example, Arranz et al. [51] proposed
an OPT design incorporating a light sheet illumination arm. The idea is to acquire the whole
volumetric information with OPT, and then target ROIs with an enhanced resolution using
light sheet illumination. In the same manner, we investigated the combination of OPT with
structured illumination microscopy (SIM).
In this last Chapter, I will provide an outlook of how we aim to combine SIM and OPT. First, I
will give a brief description of SIM and its implementation within an OPT instrument (Sec-
tion 6.1). Then I will review the remaining challenges, which have yet to be overcome and our
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strategy to solve them (Section 6.2). Finally, I will conclude this thesis with a few words on the
impact of our achievements in the duration of this work (Section 6.3).
6.1 Structured illumination microscopy with OPT
Theory and algorithm
SIM is often referenced as a super-resolution (SR) imaging technique [159, 160], but in the
combination with OPT we are interested in its optical sectioning (OS-) capacity [161, 162]. In
OS-SIM, the intensity in the sample plane is modulated with sinusoidal patterns, sequentially






with i ∈ {1,2,3}, (6.1)
where P0 is the illumination intensity without modulation, k0 the modulation frequency, and




Pi (x, y) ·O(x, y)
)∗h(x, y) with i ∈ {1,2,3}, (6.2)
where O is the object in the sample plane, h the instrument point spread function (PSF), and






(I1− I2)2+ (I2− I3)2+ (I3− I1)2. (6.3)
To simplify image processing, we used the SIMToolbox [163] developed partially by a colleague
in the group to process OS-SIM images. This toolbox is based on maximum a posteriori
probability image estimation [164]. It is an iterative approach which solves the inverse problem
of computing the OS-SIM image based on the acquired images Ii . It has the advantage of not
requiring prior knowledge of the PSF and pattern positions.
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Instrument design
The critical component of a SIM instrument is the spatial light modulator (SLM). In recent
designs, it is often a pixelated device that creates the illumination patterns by varying the
light beam intensity. There are two primary types of pixelated SLM: liquid crystals on silicon
(LCOS) [165] and digital micromirror devices (DMD) [166]. LCOS devices are a matrix of liquid
crystals on a mirror surface. They allow grayscale values of intensity modulation and have
smaller pixels. However, they are polarization-dependent. DMDs are composed of thousands
of micromirrors that can be tilted to separate the light beam into an “on” or “off” state. They
have a broader spectral response than LCOS and can be used without polarization control. We
chose to implement our OS-SIM instrument with a DMD and reuse the OPT LEDs as the light
source (see Figure 6.1). The pattern contrast is assumed to be better with a DMD when using
























Figure 6.1 – SIM instrument design. It uses LEDs and a DMD to generate a patterned illumi-
nation on the sample. The resulting fluorescence signal is collected on an sCMOS detector
through a filter set. The filter set is composed of an excitation filter EX, an emission filter EM,
and a dichroic mirror DC. A 20X long-working-distance (19 mm) objective with a numerical
aperture (NA) of 0.4 is used in view of imaging whole mouse organs. AL, aspheric lens; L,
achromatic lens (f=150 mm); M, mirror; TL, tube lens.
The OS-SIM specifications in air with a 20X Nikon objective lens (TU Plan EPI ELWD, 20X ,
NA=0.4, working distance=19 mm) are a FOV of 0.67 × 0.67 mm2 and a resolution of approxi-
mately 0.7 µm. The instrument was first implemented in a stand-alone version to evaluate
its performance without disturbing the experiments running with the OPT instrument. Ul-
timately, the OS-SIM was meant to be combined with the OPT in a single apparatus (see
Figure 6.2). The two modalities cover different scales: a whole volumetric scan with OPT
provides an overview of the sample while a series of SIM images provides high-resolution
information in selected ROIs.
Next, we qualitatively validated the OS-SIM performance with a Zeiss fluorescence test slide
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Figure 6.2 – Combination of the SIM and OPT modalities in a single instrument. The number
above each lens indicates its focal length. Fluorescence filters are omitted for clarity. After a
whole volumetric scan of the sample with OPT, regions of interest can be imaged at a higher
resolution with SIM.
(see Figure 6.3) and a 460-nm high-power LED (PT-121-B, Luminus). This sample comes
from a highly autofluorescent flower Convallaria majalis. The average of the sample images
acquired with the different illumination patterns, which corresponds to a widefield fluores-
cence microscopy version of the sample, remains slightly blurred, although the focus was
adjusted precisely (Figure 6.3(a)). The blur is mostly caused by out-of-focus light coming from
the sample part that is not contained within the imaging plane. When processed with the
SIMToolbox (Figure 6.3(b)), the patterned images give a sharper result with increased contrast
(striking examples are pointed out by the white arrowheads). A complete characterization of
the OS-SIM setup would be desirable. However, we were more concerned about the challenges
of imaging thick specimens, such as mouse organs.
Whole mouse organs prepared for OPT require submersion in a glass cuvette filled with
refractive-index-matching liquid before imaging. In the OPT instrument, this change in
refractive index along the detection axis produces negligible aberrations on the projections
because of the low (0.01) NA used. However, in the OS-SIM instrument, the NA is 0.4 with an
objective lens designed to operate in air and aberrations have to be considered.
6.2 Aberration correction
Imaging of whole mouse organs requires the use of objectives with a long working-distance in





Figure 6.3 – Validation of the OS-SIM instrument with the Zeiss fluorescence test slide. (a)
Average of the images recorded on the detector. (b) MAP-SIM result computed with the
SIMToolbox from the same images. Arrowheads point towards regions in the image where
optical sectioning improved the contrast.
solutions are usually designed for operation in air. When these objectives are used to image
in a surrounding medium that has a different refractive index, the image quality significantly
degrades as reported by Dodt et al. [168] in ultramicroscopy. Briefly, the refraction of light
occurring at the interface of a refractive-index mismatch causes strong spherical aberrations,
and the light beam fails to focus on a single point. This results in a distorted image on the
detector. To address the aberration problem, we used the OS-SIM in widefield mode, i.e.,
setting all the micromirrors to the “on” state and having a homogeneous illumination on the
sample.
The advances of mesoscopic imaging techniques over the past 20 years have recently fostered
the development of aberration-correction strategies to use commercial long-working-distance
objective lenses [10, 169]. However, these complex strategies are application- and objective-
lens-dependant. Before trying them, we decided to perform optical design simulations of
the OS-SIM instrument detection (see Figure 6.4) with OpticStudio 15 (Zemax LLC, America).
First, we modeled the objective lens with a lens tandem composed of two paraxial lenses
(f=9.5 mm, and f=−10 mm) separated by 9 mm (Figure 6.4(a)). This lens tandem has the same
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working distance (19 mm), and focal length (f=10 mm) as the Nikon objective lens. The tube
lens was a paraxial lens (f=200 mm). Then we added the BABB (10 mm) and the glass cuvette















On axis On axis




Objective lens Objective lens
Figure 6.4 – Spherical aberration correction concept. (a) Simulation of the detection rays on
the objective-lens side, a 10 mm layer of BABB and 2.5 mm of glass create an interface for
light refraction and aberrations. Blue rays come from the optical axis and green rays from
0.2 mm away in the same imaging plane. (b)-(c) Optical path difference of corresponding rays
measured in the detector plane. (d) Correction with a SIL that makes an orthogonal surface to
the rays and reduces the refraction effect. (e)-(f) Optical path differences after correction with
a SIL.
Finally, we measured the optical path difference (OPD) in the detector plane (Figure 6.4(b)-
(c)). The OPD is a quantity that expresses the deviation in the wavefront compared to an
aberration-free system. It is measured in waves, and if below 1, the imaging optics is said to be
diffraction-limited. The OPD measured with BABB and the glass cuvette wall is approximately
13 waves, which suggest that a strong degradation of the image quality will result. Images
of fluorescent microparticles with the OS-SIM instrument in air and through approximately
10 mm of BABB and 2.5 mm of glass concur the simulation result and highlight the degradation
in image quality experimentally (Figure 6.5(a), (d) and (b), (e)). The microparticle size in these
experiments was limited to minimum 5 µm because smaller ones vanished completely due to
aberrations.
Our approach to correct aberrations in the OS-SIM instrument is based on the solid immer-
74
6.2. Aberration correction

















In 10 mm BABB












Figure 6.5 – Evaluation of the aberration correction with a SIL. (a) Five-micrometer fluorescent
microparticle imaged in air with the OS-SIM in brightfield mode. (b) Microparticle imaged
through approximately 10 mm of BABB and 2.5 mm of glass. (c) Microparticle imaged through
BABB and glass and a SIL. (d-f) Corresponding cross sections along the optical axis. (g) Line
plots through the microparticles in (a)-(c) showing their profile. The air curve is dotted because
it was acquired with different exposure time, 0.02 s instead of 0.5 s for the other two. Scale
bars: 5 µm.
sion principle [170]. We modeled a solid immersion lens (SIL) that is mounted on the glass
cuvette wall (Figure 6.4(d)) and calculated a surface curvature that minimizes the refraction
at the interface of refractive-index-mismatch. This condition is satisfied when the surface is
orthogonal to the focused rays. After optimization, we measured an OPD of approximately 2
waves (Figure 6.4(e)-(f)), which is still considered to be limited by aberrations but is closer to
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the diffraction limit. Finally, we imaged microparticles with the OS-SIM instrument, and a
SIL (LA1255-A, Thorlabs) glued to the cuvette wall (Figure 6.5(c) and (f)). With the aberration
correction, the microparticle has an improved contrast when compared to the case with BABB
and glass only (exposure time of 0.5 s in both images). However, the microparticle intensity is
still lower than the one obtained when it is imaged in air (exposure time of 0.02 s).
The current aberration-correction is insufficient to image whole mouse organs prepared for
OPT. The opportunity to try more advanced aberration-correction techniques such as adaptive
optics [171, 172] however remains open.
6.3 Final words
In my thesis, we fostered the development of optical projection tomography. We started by
designing a custom instrument for whole mouse organ imaging, which was fully described
in a first journal publication (2017) [55]. This instrument was duplicated in the group of
Professor Holmberg (Lund University, Sweden) where it is available and regularly utilized as a
platform for 3D imaging of large specimens. Then, we shared our practical experience with
the instrument in a second research article (submitted to Optics Express, December 2018).
We also highlighted the use of OPT in Alzheimer’s research by imaging whole mouse brains
with amyloidosis at different ages, as described in our last article (submitted to Biomedical
Optics Express, December 2018). Our efforts were oriented towards the dissemination of the
technology and making it more accessible to inexperienced users. We went on to try bridging
the scales in combining structured illumination microscopy and OPT, following the needs of
life scientists to have an overview of their samples and high-resolution images in regions of
interest. In this context, we demonstrated the use of solid immersion lenses for the correction
of spherical aberrations arising when imaging through a cuvette and index-matching liquid.
The complete correction of these aberrations will require more advanced techniques, such as










Figure A.1 – Depth-color-coded maximum intensity projection of the vasculature in a whole
mouse lung acquired with optical projection tomography.
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Figure A.2 – Maximum intensity projection of the barbs in a cockatiel feather acquired with
optical-sectioning structured illumination microscopy. This image ranked among the top 10
winners of the “When Aesthetics meets Innovation” photo contest (EPFL, Switzerland).
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Appendix A. Image portfolio











Figure A.4 – CAD rendering of the OPT instrument.
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